^^"V^'j-^r
                  KRYPTON 85
         A REVIEW of tke LITERATURE
                      ana
                an ANALYSIS of
            RADIATION HAZARDS
           ENVIRONMENTAL PROTECTION AGENCY
               Office of Research and. Monitoring

-------
              ENVIRONMENTAL PROTECTION AGENCY
             OFFICE OF RESEARCH AND MONITORING
              TWINBROOK RESEARCH LABORATORY
The technical publications issued by the Twinbrook Research
Laboratory report results of intramural and contractor pro-
jects.  A limited number of the reports are distributed to
regional, state, and local radiological health agencies, to
universities and libraries, to other government and private
agencies, and to interested individuals.

Twinbrook Research Laboratory technical reports are generally
available from the National Technical Information Service,
Springfield, Virginia 22151.  Microfiche copies are $0.95 and
paper copies are $3.00 unless otherwise noted.

-------
         KRYPTON 85
A REVIEW of tke LITERATURE
               ana
         an ANALYSIS of
    RADIATION HAZARDS
            William P. Kirk

   Eastern Environmental Radiation Laboratory
             P.O. Box 61
         Montgomery, Alabama 36101
ENVIRONMENTAL PROTECTION AGENCY
     Office of Research ana Monitoring
        Washington, D.C. 20460

-------
                          FOREWORD
Krypton-85 is a long-lived, fission-product, noble gas which
is released to the atmosphere in large quantities by the nu-
clear industry, primarily by reactor fuel reprocessing plants.
Although development of the technology needed to collect the
krypton- 85 at reprocessing facilities is nearing fruition, the
atmospheric build-up of krypton- 8 5 is expected to continue for
some time due to the rapid growth of the nuclear power industry.
The present atmospheric inventory of about 60 megacuries is
more than twice the inventory of a decade ago and is increasing
rapidly.  The distribution of 85Kr is essentially global once
it is released, with radioactive decay (T]/2 - 10.76 yr) being
the only important removal mechanism.

The current permissible 85Kr concentration values are based on
calculations and extrapolations rather than on the results of
di; act experimental investigation of the effects of 85Kr on liv-
ing animals.  Thorough investigation of the physiological beha-
vior and effects of °5Kr in living animals is, therefore, im-
perative.  This report summarizes the background information up-
on which studies of this type, being undertaken at the Eastern
Environmental Radiation Laboratory, Montgomery, Alabama, are
based.  Additional information is sought on a continuing basis,
and the interest and comments of all those concerned with radio-
logical and environmental health are solicited.
                                      William A. Mills, Ph.D.
                                      Director
                                      Twinbrook Research Laboratory
                           ^^^

-------
                           TABLE OF CONTENTS
Foreword
Abstract
Acknowledgments
INTRODUCTION  ...........................  1

BACKGROUND INFORMATION ......................  1
  Characteristics  ........................  1
    Chemical  ...........................  1
    Physical Data  ........................  2
    Radiological Data  ......................  3
  Source Information .......................  3
  Present (MPC)a and Rationale ..................  4

85KR AS AN ENVIRONMENTAL CONTAMINANT ...............  5
  How and When 8%r is Released to the Environment ........  5
  Distribution of 85Kr ......................  7
    Worldwide Concentration and Dose Estimates ..........  7
    8%r Concentrations and Doses Near Reprocessing Facilities .  . 10
  Removal of  85Kr from Process Streams Before Release to the
       Atmosphere  ........................ 11

USES OF KRYPTON 85 ........................ 13
  Medicine and Closely Allied Areas  ............... 13
  Non-medical Uses of 85Kr .................... 14

RADIATION HAZARDS ASSOCIATED WITH 85KR .............. 15
  Skin Dose   ........................... 15
  Dose in the Body ........................ 16
    Dose from 85Kr Outside the Body  ............... 16
    Dose from °%r Contained in the Body ............. 16
  Doses to Skin, Whole Body, and Male Gonads at
       Unrestricted (MPC)a .................... 17
    Skin ............................. 17
    Gonads (Male)  ........................ 17
    Whole Body .......................... 17
  Other Dose Calculations  .................... 18
  Comparison of Doses Delivered at the Unrestricted (MPC)a
       With Permitted Doses  ................... 19
  Unexplained Phenomena Involving Noble Gases  .......... 21

-------
 SAMPLING AND ANALYSIS OF  85KR	.22
   Detection and Counting   	  .22
     General	-22
     Detectors Used	.22
       GM Counters	22
       Internal lonization and  Proportional Counters  	  23
       Scintillation  Counters   	  23
        Gamma Scintillation	23
        Beta Scintillation	23
       Semi-Conductor Detectors	25
     Calibration and  Standardization  	  26
   Sampling and Sample Preparation	26

 SUMMARY	27

 REFERENCES	29

                                TABLES

   1.   Annual Dose from Immersion in Air with a Concentration
       3 x 10"7 pCi/cm3  .	18
   2.   Summary of Dose Limits for Individuals	19
   3.   Minimum Detectable  8%r Concentrations for Calibrated
       External Beta  Counters	24
   4.   Minimum Detectable  Concentrations of °%r in lonization
       Chambers	25
 A-l,   Solubility Coefficients  for  yi>Kr in Various Solvents  .... SO


                               FIGURES

   1.   Scheme of Hydroquinone Clathrate  	  2
   2.   Estimated Krypton-85 Concentrations in Air, 1970-2060 ....  6
   3.   Estimated Annual Doses from Krypton-85, 1970-2060  	  7
   4.   Comparison of  Estimated 8%r Concentration in Air
       1970-2060, with Measurements through 1970	8
   5.   Krypton-85 Concentration in Air 	  9
   6.   Estimations of Annual Dose Rates from 8%r	10
   7.   Comparison of  Estimations of Annual Dose Rates from ^%r   .  . 20
A-l.  Hypothetical 8%r Saturation and Desaturation Curves for
       Standard Man	55
A-2.  Experimental 85Rr Desaturation Curves in Rat   Short
      Exposure  	 55
A-3.  Experimental ^%r Desaturation Curves in Rat - Long
      Exposure  	 55

                             APPENDIX A

Absorption of Kr into the Body	47
Appendix Reference   	 57

                                vi.

-------
                                ABSTRACT

     This review summarizes most of the existing information on  °%r.
Major subject areas covered are (1) physical, chemical and radiological
data, (2) maximm permissible concentration in air  (MPC)a and its
rationale,  (3) source data, (4) atmospheric concentrations and dose
estimates near reprocessing facilities and worldwide,  (5) proposed
control methods, (6) uses in science, especially medicine, and industry,
(7) calculations of dose to various organs and their relationship to
the (MPC)a,  (8) unexplained noble gas phenomena, and (9) methods of
sampling and analysis.

     The -In vivo internal behavior of °%r is discussed in detail in
appendix A and preliminary desaturation curves obtained with rats are
presented.  The review includes 280 references.

-------
                      ACKNOWLEDGMENTS

     This report was written as part of the Ph.D.  dissertation
in the Department of Radiation Biology, School of Medicine and
Dentistry, University of Rochester,  Rochester, New York.

     The author wishes to especially thank his faculty advisor,
Donald A. Morken, Ph.D.,  for his support and assistance in its
evolution and a host of University Librarians for their assistance
in collecting the mass of reference  material used.

-------
                              INTRODUCTION
     Krypton 85 is one of the most important gaseous contaminants produced
in nuclear fission.  Public health concern has centered on its release to
the atmosphere during reactor operations and especially during fuel repro-
cessing.  Rapid expansion of the medical, scientific and industrial uses
of 85j(r have made it of practical importance to the health physicist.  The
literature on &%r is singularly parochial and is spread through many dis-
ciplines with little cross-referencing.  This report reviews much of_this
literature and provides general information and  references regarding 85Kr.
The reference list is not complete, particularly with respect to some
government reports from this country and abroad which are difficult to
locate and obtain, and to the rapidly proliferating field of medical uses.
This report specifically attempts to:
                                                              o r
     1.  Furnish physical, chemical, and radiological data on o;>Kr
     2.  Review sources, yields, and amounts released in different
           operations
     3.  Review the current maximum permissible concentrations in air
           (MPC)a values and their rationale
     4.  Review the status of SS^r as an environmental contaminant
           and proposed methods of control
     5.  Enumerate a number of uses for ^Kr in science, especially
           medicine  and industry
     6.  Evaluate the radiation hazard associated with 8%r and
           relate it to existing limits
     7.  Review methods that have been successfully used to collect,
           prepare and analyze ^Kr.
                         BACKGROUND INFORMATION


                             CHARACTERISTICS

CHEMICAL

     The family of noble gases that includes krypton has been traditionally
regarded as chemically inert.  Modern studies have revealed, however, that
the more polarizable members can participate in ionic or covalent bonding,
under appropriate conditions, with highly reactive elements such as fluo-
rine and oxygen (1,2) and that clathrates  can be formed with water
       A clathrate is a solid that incorporates a gas into voids in its
 crystal structure.  See figure 1.

-------
 (hydrates) and a number of organic solvents (1,3,4,5).  Most of these
 compounds dissociate at physiological temperatures but some of the organic
 clathrates, including hydroquinones, are relatively stable at normal tem-
 peratures (4,5).  The structure of hydroquinone clathrate is shown in
 figure 1.  Several authors have postulated clathrate formation involving
 side chains on body proteins to explain the observed narcotic effects of
 xenon, the most reactive noble gas, and other gases that produce similar
 reactions (3,6,7,8).  The noble gases are highly soluble in non-polar
 solvents, including body lipids, with solubility decreasing in order of
 radon, xenon, krypton, argon, neon, and helium (9).   Solubility is dis-
 cussed in more detail in Appendix A.
                            BENZENE RINGS
       Figure  1.  Scheme of hydroquinone clathrate,  after  Balek (5)
PHYSICAL DATA

     Cryogenic Reference Data (10)  and the Radiological Health Handbook
(11) give the following information concerning krypton:

-------
     Atomic weight  (naturally occurring) =83.9
     Melting point  = -157.2° C  (-250.9° F)
     Boiling point  = -153.3° C  (-244° F)
     Triple point = -157.2° C,  548.2 mm Hg (-251° F and 10.6 PSIA)
     Critical point = -63.8° C  (-82.8° F) and 41,165 mm Hg  (796 PSIA)

One kg of natural krypton occupies a volume of 287.45 liters at NTP
(20° C, 760 mm Hg)  or 266.79 liters at STP ( 0°C 760 mm Hg).

     The naturally  occurring isotopes of krypton and their percentage
of natural abundance are 78Kr (0.35%), 80Kr (2.27%), 82Kr  (11.56%),
(11.55%), 84Kr  (56.9%) and 86Kr  (17.37%).  Radioactive isotopes of
krypton include 74-77, 79, 79m,  81, 81m, 83m, 85, 85m, 87-95, and 97.
RADIOLOGICAL DATA

     The following data are given by the Radiological Health Handbook (11)
or the National Bureau of Standards (12) for 85Kr:

     Half life = 10.76 years              _
     Emissions:  Beta;  ^^ = 0.672 MeV, E = 0.249 MeV, frequency =
       99.59%  (11) or 99.56% (12).  A 0.16 MeV E,^ beta, which is
       usually ignored in calculations, is associated with the 0.514
       MeV gamma.
                 Gamma; E = 0.514 MeV, Branching ratio = 0.41% (11) or
       0.443%  (12).

     Revisions in the published values have occurred and are the cause of
most differences in doses or dose rates calculated by different authors.
                           SOURCE INFORMATION
                   o c
     The amount of   Kr formed depends on a number of factors including
the specific heavy nuclei being fissioned, the neutron flux, the neutron
energy spectrum, and the irradiation time.  The amount present at anal-
ysis will be determined by the foregoing factors and the time that has
elapsed between irradiaton and analysis, or cooling time.  The general
expression for the amount of °^Kr present in a reactor or fuel element is:

               C = 8o4 x 105 P^  (1  -  e-^T)  e-^t              (13)

where:   C = curies of 8%r present
        Pi = total nuclear power supplied by reactor system i, MW
        Yi = fission yield of system for 85Kr
         A- = decay constant for 85Kr = 1.76 x 10'4 days'l
         T = irradiation time (days)
         t = cooling time (days)

-------
Various estimates of Y^ in the literature include:

     Yi (235U, thermal neutrons) = 0.00293 (14); 0.00273  (15);  0.00306  (16)
     Y-J (235u, fission neutrons) = 0.00310 (16)
     YJ; (239pu, thermal neutrons) = 0.00099 (15); 0.0012  (16)
     Y- (239pu, fission neutrons) = 0.001446  (16)
     Yi (239pu} fast neutrons) = 0.00076 (17)
     Yi (233u, thermal neutrons) = 0.0058 (14)
An estimate of average ^^>Kr production is 0.2 kCi per megawatt of  energy
produced  (1 year operation, 1 day cooling) (18) .
                  PRESENT  (MPC)a VALUES AND RATIONALE

     The presently accepted maximum permissible concentrations  in  air  for
85Kr, as established by the AEC (19), NCRP (20), and ICRP  (21), are  3  x
10~7 i^Ci/cm3  (3 x 105 pCi/m3) for unrestricted areas, lO'5 jjCi/cm3
(107 pCi/m3) for occupational exposure for 40 hours weekly, and 3  x  10-6
      3  (3 x lO^pCi/nP) for occupational exposure for a 168 -hour week.
     The  (MPC)a values and the estimated doses in most published pro-
jections are based on calculations of the external dose received by  a
person standing in an infinite hemispheric cloud of the radioactive
gas .  This is standard procedure for noble gases .3  Internal absorption
or concentration is not considered.  The occupational (MPC)a for a 40-hour
week is calculated from the formula:
                   (MPC)  =  -°.R Pa (pa/Pt,>
                        a
where:  R = dose permitted in one week  (rem)
        Pa = density of air (0.00129 g/cm3)
     Pa/pt = stopping power of air relative to  tissue
            ( = 1/1.13 for beta and secondary  electrons produced by x or y
            radiation)
     2(E) = effective energy per disintegration  (MeV)
Two sub -categories are recognized.  If the radiation emitted is  gamma
radiation or beta radiation with maximum energy equal to or greater  than
0.1 MeV, the critical organ is taken to be the whole body and R  is set
at 0.1  rem/week.  If the emissions are alpha particles or beta particles
with maximum energy less than 0.1 MeV, the critical organ is considered
to be to the skin of the whole body and R is taken to be 0.6 rem/week.
Krypton 85 falls in the former group and is considered to deliver its
dose to the whole body even though the deposition of energy from exter-
nally incident 0.672 MeV beta particles will be deposited within about
a 2 mm  depth in tissue (11,22)  with the average penetration being slightly
greater than 0.2 mm (22).  The overall effect  is to overestimate the dose
     zThe lung is used as the critical organ for radon  in  equilibrium with
its daughters.

-------
actually delivered  to  the whole body.  This will be discussed in detail
later.  It has been recognized that the MFC values in use are conserva-
tive  (23,24), and the  next  issue of the ICRP Recommendations is expected
to  increase  them by a  factor of about 5 (24).
                   85KR AS AN ENVIRONMENTAL CONTAMINANT


            HOW AND WHEN 85KR  IS RELEASED TO THE ENVIRONMENT

     Krypton  85 is produced by nuclear explosions and continuously
during  reactor  operations.  It has been concluded (25,26), from consider-
ations  of experimentally determined  air concentrations versus total weap-
ons yield,  that most  of  the 8$Kr in  the air, even during a period of
active  atmospheric weapons testing,  is due to reprocessing of reactor
fuel.   This conclusion is strongly supported by evaluation of the data
of Logsdon and  Chissler  (27) and Kahn et al, (28) which shows that about
0.02% of  the  8%r  formed in reactor  operations from 1959 through 1968
was released  to the air  at the reactor.3  The °%r produced in reactor
fuels is  not  released, in the  absence of cladding failure or "tramp"
uranium,4  until the fuel elements are cut apart in the reprocessing plant
and the fuel  is dissolved preparatory to chemical separations.  Goode (29)
reported  that 99-99.51 of the  release occurs in the dissolution phase with
acid treatment  of  Th02-U02 fuel in the laboratory.  This estimate is con-
firmed  for full scale processing by  data of Cochran et qi% (30) who report
that all  but  about 20-50 curies of the approximately 5,0"00 curies of 8%r
released  per  batch processed at the  Nuclear Fuel Services plant are
released  during dissolution.   Other  radioactive gases released during
reprocessing  include  131I, 129I, 131mXe, 133Xe and 3H.  Krypton 85 is
the only  gas, other than 3H, released in sufficient quantity and having
a half  life long enough  to produce significant widespread concentrations
in the  air.   Whipple  (50) estimates  that 8%r emission will limit U.S.
nuclear power to about 150,000 MW(e) ,5
     s Assuming 0.2 kCi of ^Sftr produced/MW-year , all beta-gamma activity
released to- air by PWR/HTGR was 85Kr and 0.001% of total fission gas re-
lease from BWR was °%r  (Estimated from isotope composition data in 27,28).
     4 According to Kahn  et al. (28) , the principal sources of fission
products in reactor coolant are holes or cracks in cladding or fission of
uranium in the coolant that has escaped from failed fuel elements.  Tramp
uranium and direct diffusion through intact cladding are minor sources .
     5The release limit by the U.S. power industry was determined to be
1010Ci/year assuming  (a) (MPC)a of 3 x 10 -7 |j,Ci/cm3 reduced by 1/3 for
individual variations and 1/10 for summing of dose from several isotopes,
(b) half the 85Kr released is from explosion (U.S.), (c) all 85Kr produced
is released, and (d) the U.S. uses 0.06 of world capacity (fair share
based on population) .

-------
     Small amounts of  85Kr have been released by venting of cavity gas
from certain Plowshare projects such as Gasbuggy and  Rulison.  Gasbuggy
produced an estimated  350  Ci of 85Kr which resulted in a cavity gas con-
centration of 2.8 ^Ci/ft3  (31,32).   Hie 85Kr concentration in the cavity
decreased exponentially  as gas was  removed (32-35).   The amount of o:>Kr
released by these tests  is minor in comparison to  total 8:>Kr releases,
but is of the same magnitude as the amount of "Kr released at reactor
sites through 1968.
              100.00  -rr
               10.00 -
                1.00  -
               0.10  -
               0.001
                                                I      I
                              I
                            /
                            i
                            A
                            i
                            A
— MEDIAN ESTIMATE
^ RANGE OF VALUES FOR DILUTION
   IN ENTIRE ATMOSPHERE
^ UPPER RANGE FOR 75% RELEASE
   IN NORTHERN HEMISPHERE
 1  AVERAGE FROM REFERENCE 25
                     1940   1960  1980  2000  2020  2040  2060

                                      YEAR
    Figure 2.   Estimated krypton-85  concentrations in air,  1970-2060.

-------
                           DISTRIBUTION OF 85KR

WORLDWIDE CONCENTRATION AND DOSE ESTIMATES

     Colemen and  Liberace (13)  estimated future world 8%r levels, and
radiation doses resulting therefrom,  based on projected world energy
requirements and  that part expected to be met with nuclear power.  Their
estimates, shown  in figures 2 and 3,  assume that all 85Kr produced is
released and that the (MPC)a actually delivers the permitted dose.  Their
estimates of air  concentrations, published data from a number of labor-
atories (25,26,36-45),  and estimates  of the United Kingdom contribution
            100.00
             10.00  -J
              1.00  -J
              0.10  -J
              0.01   -J
              0.001  -
— MEDIAN ESTIMATE
   RANGE OF VALUES FOR DILUTION
   IN ENTIRE  ATMOSPHERE
   UPPER RANGE FOR 75% RELEASE
   IN NORTHERN HEMISPHERE
                   1940  1960  1980  2000  2020  2040  2060

                                     YEAR
      Figure  3.   Estimated annual dose from krypton-85,  1970-2060.

-------
 (24)  were converted to a common unit and are  shown in figure 4.6  Data
 from Shuping e~t al.  (44,45) are shown in figure  5 with the time scale
 expanded.   The 85Kr levels appear to be increasing at a rate near or
 slightly greater than the predictions.  The predictions were not claimed
 to  be accurate in the 1965-1980 period mainly because of uncertainty in
 the time delays from irradiation to reprocessing.
                  10'
              o
                  10
                    3
              1
10' -.
        REFERENCE
      + (37)
      A (38)
      O (46)
      D (36)
      * (25)
      V (26)
      
-------
IO


16-

^^
N U-
^ 12-
%
> 10-
"^
v^
'^ p
°O O


6-

CHESTER, WEST VIRGINIA A
CLEVELAND, OHIO •
MUNICH, GERMANY •
ESSINGTON, PENNSYLVANIA O
LYON, FRANCE D
ONTARIO, CANADA A


• •
.s
^^
^x^C
^^x" ^EHHALT
^ HEIDELBERG,GERMANY

1962 1964



D

•
^^ ^^
• ^
0 0 • A
B o 0 A
0
0
o



AFTER SHUPING et.al. (44, 45)
1966 1968 1970
                    MIDPOINT  OF COLLECTION PERIOD

   Figure 5.  Krypton-85 concentration in air,  including data  from
                        Ehhalt et at.  (25) .
     The data from figure 3 have been replotted in figure 6 for compari-
son with similar estimates from Dunster and Warner (24),  Cowser et  al.
(46,47) and Csongor  (38).  The U.K. estimates (24) are based on de  novo
dose calculations while the others assume that a dose of  0.5 rem is de-
livered when the average concentration is 3 x 10"^ |j,Ci/cm3 for one  year.
The calculations involved are discussed in the section on hazard
evaluation.

     Krypton 85 in commercial krypton supplies began causing problems as
early as 1963 when Ostroski and Jelen (43) reported background problems
with krypton-filled ionization chambers.  Lasseart and Kellershohn  (48)
reported similar problems with self-triggering spark chambers in 1965.
Dunster and Warner (24) warn of the possibility of personnel hazards asso-
ciated with handling commercial krypton supplies long before atmospheric
concentrations present a significant problem.

     For comparison, the cumulative whole-body radiation  dose from  all
nuclear testing conducted through 1962 (end of large scale atmospheric
tests)  is estimated to be 110 mrem in 30 years (49), which is itself
about 1/30 of the dose received from natural sources over the same  period
(peak dose rates from fallout are greater).

-------
10
              100.00 -={
               10.00 -
                1.00 -
           is
           J  0.10  -
               0.01  -
               0.001
                          REFERENCE
                       O (47,48)
                       D (38)
                       A (24)UK FROM WORLD TOTAL
                       + (24)UK FROM UK
                                   SKIN
                                               (13)
                                        COLEMAN & LIBERACE
   £, GONADS
                                 /S
   +

SKIN
                                 /GONADS
                    1940   1960   1980  2000  2020  2040  2060

                                     YEAR
      Figure 6.   Estimations of annual dose rates from 85Kr.
85KR CONCENTRATIONS AND DOSES NEAR REPROCESSING FACILITIES

     Personnel of the Northeastern Radiological Health Laboratory of the
Bureau of Radiological Health, PHS, DHEW,  have investigated the 85Kr con-
centrations in the vicinity of the Nuclear Fuel Services reprocessing
plant at West Valley, New York, which is  the only operating commercial
fuel processing facility.  These data are  reported in references (30)
and (51).  Concentrations were monitored,  as near to the periphery of
the NFS property as access roads permitted, during the dissolution of
several batches of fuel (about 1 ton/batch).  Using data collected in

-------
              ENVIRONMENTAL PROTECTION AGENCY
                  Office of Research, and Monitoring
                     12720 Twinbrook Parkway
                    Rockville, TYlaryland 20853
                          March 1, 1972
ERRATA SHEET:

          Please make the following corrections on page 11,

lines 5 and 6 of the report:  "Krypton 85, A Review of the

Literature and an Analysis of Radiation Hazards."
          ".... annual doses of 0.05 rem and 0.03 rem
          respectively, ..." should read "	annual
          doses of 0.05 mrem and 0.3 mrem respectively...'
                                    Donald M.  Hodge
                                    Chief, Technical Reports Office

-------
                                                                        11
1968 and early  1969, Shleien  (51) reported that the average annual 85Kr
concentration at  the plant boundary  (1.5 km from the stack) would be 2.3
x lO'll n-Ci/cm3 and that  the maximum annual concentration would be 1.3
x 10~10 liCi/cm^.  These values, derived from plume measurements using
wind data and diffusion equations, correspond to annual doses of 0.05
rem and 0.03 rem  respectively, if the ICRP values are used to convert
the concentrations to doses.  In a later report, Cochran &t o3>. (30)
reported that the S^Kr concentrations in the plume ranged from 1.7 x
10   to 7.65 x  10~7 n-Ci/cm3 average  for a 3-hour dissolution cycle;
the peak values during the same time were 1.3 x 10"7 to 9.3 x 10"6
They calculated that the  highest annual concentration, 1.7 x 10"10
would occur at  the property line in  the north octant.  The maximum 24-hour
off-property concentration was estimated to be 6.8 x 10"7 uCi/on3.  Sax
et &l.  (36) reported a concentration of 5.6 x 10~^ ^ci/cnP about 5 miles
from the plant  on one occasion in February 1968.

     Dunster and  Warner  (24) estimate that the dose to individuals in the
vicinity of United Kingdom reprocessing facilities in 2000 AD will be
about 45 mrad/year to the skin and 0.38 mrad/year to the gonads.
               REMOVAL OF  85KR FROM PROCESS STREAMS
                BEFORE RELEASE TO THE ATMOSPHERE
     It seems  improbable that overall atmospheric   Kr concentrations
will require corrective or preventive action on purely radiological
safety grounds before sometime in the next century  (13,24).  However,
the anticipated growth in size of reprocessing facilities, coupled with
increasing cost of enough land to permit MPC to be reached by diffusion
before the plume crosses the property line, will probably lead to instal-
lation of equipment to remove the 8%r from the process stream before it
leaves the stack.  Blomeke and Perona (52) and Perona et «I.(53) estimate
that this point will be reached when more than 5 tons/day of 150-day aged
fuel or 0.5 ton/ day of 30-day fuel is reprocessed.7  East Germany re-
quires facilities for storing 8%r originating in reprocessing plants (54)

     Concern with removal of 85Kr dates to the late 1950's (13,55-57).  A
number of techniques have been investigated including:

     1.  Adsorption onto activated charcoal at cryogenic temperatures
           (24,58-61 and many others)
     2.  Solvent extraction (24,42,55,56,62-64)
     3.  Condensation in liquid nitrogen followed by fractional distil-
           lation (65)
     4.  Selective permeating through cellulose acetate or silicone
           rubber membranes (66,67).
     7Their analysis included contribution from all noble fission gases,
but only 85Kr is important 150 days after cooling.

-------
12
 Three of these techniques have been developed to the operating  stage.
 The  solvent extraction method developed at the Oak Ridge Gaseous Dif-
 fusion Plant over the past several years  (63,64) was recently reported
 to be commercially available (62).  A plant using the LN2 condensation-
 redistillation technique is in use at the Idaho Chemical Processing
 Plant (NRTS) (65).  Air and Water  News (62) also reports that  one  com-
 mercial reactor supplier is using a charcoal bed removal system.

     The most practical disposition for recovered 85Kr appears  to be
 long-term storage in high pressure steel cylinders (24,52,53).  Incor-
 poration of 85Kr into glasses, resins, clathrates, molecular sieves, and
 pressurized steel or glass bulbs in an epoxy matrix have been considered
 for  secondary containment of the 8%r inside the steel cylinders  (68) .
 Serious attention has been given to the possibility of pumping  85Kr into
 underground storage areas, such as abandoned gas or oil wells or similar
 formations  (52,69,70).  This method requires a porous storage formation
 with an essentially non-porous cap formation that is free of vertical
 channels.  This requirement is too restrictive to permit generalized
 use  at reprocessing plant sites.

     One comprehensive proposal, made by Blomeke and Perona (52,53),
 calls for separating the 8%r from the process stream, alone or with
 xenon, by solvent extraction or cryogenic distillation.  Processing
 2600 tons/year of LWR8 fuel is estimated to yield 28 cylinders, each
 containing  50 liters or 106 Ci of 85Kr  (heat production  5,800 BTU/hour),
 or 160 cylinders each containing 50 liters of mixed Kr/Xe (180,000  Ci
 8^Kr, heat production 1000 BTU/hour).  The cylinders would be temporarily
 stored underwater on site and then shipped, in special water-cooled casks,
 to underground salt mines and stored above the floor in sealed  rooms.
 The  storage space requirement for one year's production is one  quarter
 acre and is determined by heat production.  The cost of disposal of °->Kr
 by this technique, including (1) filling, testing, and on-site  storage
 of the cylinders, (2) shipment to a salt mine, and (3) permanent storage
 in the salt mine, is estimated to be $190,000-220,000/year for  a 2600  ton-
 year plant.  This amounts to 0.0003-0.00035 mills/kW-hr of electricity
 generated by the reprocessed fuel.  This is about 0.001% of the residen-
 tial electric rate in Rochester, New York in 1971.

     Dunster and Warner (24)  make basically similar proposals except that
 they consider solvent extraction or adsorption on activated charcoal to
 concentrate the 85Kr and evaluated several different types of storage
 tanks.

     8The fuel considered is  from a light water reactor  (LWR)  exposed
 to 33,000 MWd/ton at 30 MW/ton.   An equivalent amount of fuel from a
 liquid metal fast breeder reactor (mixed core and blanket)  with an aver-
 age  exposure of 33,000 MWd/ton at 58 MW/ton will yield about 10% less
volume of noble gases.

-------
                                                                         13
                          USES  OF KRYPTON 85
                MEDICINE AND CLOSELY ALLIED AREAS

     Krypton  85 has  found  important clinical  use in the past 15 years.
Its physiological  characteristics  of low blood solubility,  high lipid
solubility, and rapid diffusion, together with versatility  of detection,
facilitate differential  diagnosis.   Specific  applications have included:

     1.  Determination of  total body fat (71-75)
     2.  Circulatory studies
          a.   General (72,  76-86)
          b.   Rate of blood flow
                (1)   Brain
                     (a)  Whole and regional (87-116)
                     (b)  Partition coefficients (100,  117,  118)
                     (c)  Detection of  lesions (87,  102, 119)
                (2)   Heart
                     (a)  Output  (120-125)
                     (b)  Myocardial flow (126-132)
                (3)   Lungs  and perfusion (133-140)
                (4)   Kidneys (108,  141-146)
                (5)   Skin (147-149)
                (6)   Gastric mucosa (150-152)
                (7)   Intestines  (153-155)
                (8)   Liver  (156,157)
                (9)   Eyes (158, 159)
               (10)   Muscle  (106, 160)
               (11)   Testis  (161)
               (12)   Tumors  (162)
               (13)   Fresh  grafts (163)
          c.   Circulatory  shunts
               (1)   Left -to -right,  including  atrial septal  defects,
                      ventricle septal  defects , and patent  ductus
                       (164-173)
               (2)   Right  to left  (pulmonary)  (168, 174-179)
               (3)   Hepatic -pulmonary  (177)
               (4)   Hepatic to vena cava (180)
               (5)  A-V  aneurisms  in brain  (117)
     3.  Lung  function studies - emphysema, cysts,  cancer etc.
           (133-140,  181-183)
     4.  Structure of teeth (crystalline)  (184)
     5.  Determination of surface  area  of elastin (185)
The quantities of ^^Kr used in these  studies have usually been in the
p.Ci-mCi range.

-------
14
                        NON-MEDICAL USES OF 85KR

     The non-medical uses of 85Kr can be divided into two areas:   (1)
 those  that use 85Kr as the gas and (2) those that incorporate it into
 solids prior to use.  Examples of the first category are:

     1.  Replacement of radium bromide as an ionization source in cold
           cathode gas discharge tubes (186)
     2.  Location of carbon monoxide leak into aircraft cabins in
           flight (187)
     3.  Measurement of stream aeration (188)
     4.  Determination of surface area of atmospheric particulates  (189)
     5.  Measurement of gas flow in piping systems  (190)
     6.  Tests of gaseous diffusion theory in solids (68, 69, 191)
     7.  Measurement of stack gas dispersion and diffusion  (31, 192-197)
     8.  Study of interhemispheric atmospheric mixing (39)
     9.  Study of other atmospheric gases (40, 41)

     Krypton 85 has been incorporated into or onto  solids using techniques
 recently reviewed by Balek (5) and by Eddy  (198).  Methods  include:   (1)
 fission recoil,  (2) bombardment of surfaces with high-energy °5Kr ions,
 (3) diffusion into crystal lattices at high temperatures and pressures
 (successful with over  150 materials) , (4) crystallization  of solids from
 melt or by sublimation in an 8%r atmosphere and (5) by adsorption  onto
 outgassed surfaces.  All but the last method yield more or  less stable
 products which are called kryptonates if surface labeled, as by the first
 three  methods, or clathrates if the 8%r is incorporated throughout the
 material as by the fourth method.

     The distribution of 85.Kr can be determined by  autoradiography, or
 its electronic equivalent, and used to study structural features of solid
 materials including surface phenomena, lattice structure, or channeling
 (5, 199-201).  Cracks and imperfections in machinery components, such as
 turbine blades, can be detetected after either kryptonation or adsorptive
 labeling.  Autoradiography is the only technique sensitive  enough  to use
 with the.Jcryptonated materials while either autoradiography or electronic
 imaging works well with the adsorptive technique.

     Another potentially extensive use of kryptonates and krypton  clath-
 rates  lies in the field of chemistry  (4, 5, 202).   Krypton  85 can be incor-
 porated into one of the reactants, catalysts, or incidental materials, and
 the release of the gas from the solid used to detect the beginning  of
 a reaction or to measure its rate.  Reaction end points, such as in titra-
 tions, can be objectively determined by including in the solution a kryp-
 tonated solid that will not react until an excess of titrant is present.

     The amount of 85Kr involved in non-medical uses is rarely mentioned;
however, some of the counting data presented and description of the pro-
 cedures suggest that some procedures may use curie  quantities.

-------
                                                                     15
                  RADIATION HAZARDS ASSOCIATED WITH
                                 SKIN DOSE

      The  dose to the skin from a cloud  of    Kr  is  the  sum. of doses  from
beta particles,  gamma rays  and Bremsstrahlung  from the surrounding atmos
phere and from the 85Kr that has been absorbed  into the body.   In the cir
cumstances postulated in deriving the  (MPC)a, only the contribution from
outside the body is significant; the internal contribution will be  1-2
orders of magnitude less than the external  gamma/Bremsstrahlung component
and  4-5 orders of magnitude less than the dose  delivered to the skin by
external  beta radiation.

      The  surface beta dose in an infinite cloud of a beta-emitting  gas
such as 8bKr is  given by:

      D =  1.07 x  10-6 CaE K rad/hour                    (24)

where:  C^ = pCi 85Kr/gram of air
        E  = average beta energy in  MeV = 0.249 MeV9   (11)
        K  = ratio of stopping power in tissue  to  stopping
              power in air =1.15                      (24)

This  reduces to:

      D =  3.064 x 10"7 Ca rad/hour =  2.68 x  10"3 Ca rad/year
      or
      D =  2.07 Ca rad/year where Ca = pCi 85Kr/cm3  air10

This  equation represents 50%  of the  point dose  at  the  center of an  infi-
nite  cloud of 85Kr or the dose at the surface of an infinite slab of
multiplied in either case by the stopping power ratio.

      The  expression for the dose to  the surface of the body from gamma
radiation and Bremsstrahlung was derived by N.  Adams in Appendix 1  to
reference (24).   This dose is given  by  the  expression:

      D =  2.42 x  10"9 Ca rad/hour = 2.12 x 10'5  Ca  rad/year
      or
      D =  1.64 x  ID'2 Ca rad/year

where C =  pCi 85Kr/gram of air and Ca = pCi 85Kr/cm3 of air as  above.
     9Reference  (24) uses 0.234 MeV.  Results differ accordingly.
    10Using 1 cm3 air = 0.001293 gram air.

-------
 16
                            DOSE  IN THE BODY

 DOSE FROM 85KR  OUTSIDE THE BODY

      The average  dose to the total body from gamma radiation and
 Bremsstrahlung  from 85Kr outside  the body  (infinite  cloud)  is given by
 (24 -Appendix 1) :

      D = 1.97 x 10-9 ca rad/hour  = 1.73 x  10 -5 Ca rad/year
      or
      D = 1.38 x 10 ~2 Ca rad/year


 DOSE FROM 85KR  CONTAINED IN THE BODY
      To  calculate the dose of    r in the body that results from  a given
 concentration of the isotope in the surrounding air, the fraction of the
 air  concentration that will ultimately be found in the body, or a specific
 part thereof, must be known.  This faction is the partition coefficient
 which is usually designated as ^,
                              o r
      The internal behavior of   Kr is discussed in detail in Appendix A,
 including  gas solubility, partition coefficients, and kinetic parameters.
 The  partition coefficient for the body or a particular tissue is  largely
 dependent  on its fat content and for °5Rr is closely approximated by:

      A. tissue: air = 0.06 (9Vf + Vrj = (0.48Vf/VtJ + .06
                            Vt

 where:  Vt = total tissue volume, Vt = Vf + Vr
        Vf = volume of fat in tissue
        Vr = volume of rest of tissue

 Thus  the partition coefficients from body tissue to air ranges from  0.06
 to 0.54.  The average partition coefficient for standard man is 0.163

     To calculate the tissue concentration of 85Kr at equilibrium, the
 air concentration is multiplied by the partition coefficient.  If  tissue
 density is unity,  the result is in pCi/gram.

     The dose which results from the gamma and Bremsstrahlung component
 of "Kr in the body is given by (24, Appendix 1) :

     D = 1.43 x 10-9 Ctrad/hour = 1.25 x 10~5 Ctrad/year

where Ct = pCi 85Kr/gram of tissue (Ct = C£ x jj

     The beta component of internal dose is given by:

-------
                                                                        17
     D = CtpCi/g x 2.22 disintegrations/pCi-min x 0.9959 beta/dis-
         integration x 0.249 MeV/beta x 1.6021 x 10"6 ergs/MeV x
         rad-g/100 ergs x 60 min/hour
       = 5.29 x 10-7 Ctrad/hour = 4.62 x 10"3 Ctrad/year

If X air:tissue = 0.06; D = 2.77 x 10"4 C' rad/year
   X air:tissue = 0.163; D = 7.58 x 10~4 C^ rad/year
   X air-.tissue = 0.54; D = 2.50 x 10'3 C4 rad/year

where C^ = pci 85Kr/cm3 in the surrounding air.
    DOSES TO SKIN, WHOLE BODY AND MALE GONADS AT UNRESTRICTED (MPC)a

    An individual continuously submerged in an infinite cloud of 85Kr at
a concentration of 3 x  10~7 yCi/cm3  (C' = 0.3 pCi/cm3, with an air density
of 0.001293 g/on3 C  =  232.56 pCi/g air) receives the following annual
doses.             a
SKIN (SURFACE)
     External beta dose = 2.073 C^ rad/year =                    0.623   rad
     Gamma and Bremsstrahlung dose = 1.64 x 10"2   C^ rad/year a 0.00495 rad
                                                         Total = 0.628rad
GONADS (MALE)
     Gamma and Bremsstrahlung dose at surface =
     1.64 x 10-2 C  rad/year = 4.93 x 10~3 rad
     Gamma and Bremsstrahlung dose from    r inside the body (\ = .06)  =
     1.25 x 10'5 Ct rad/year = 7.5 x 10~7 C' rad/year = 2.25 x 10'7  rad
                                           3.

     Internal beta dose (\ = .06) =
     2.77 x 10~4 C^ rad/year =      8.33 x 10'5 rad
                        Total       5.01 x 10~3 rad
WHOLE BODY  (\ =  0.163)

      Gamma and  Bremsstrahlung  dose  from 85xr  outside  the body  =

      = 1.38 x ID'2 C^ rad/year =  4.02 x 10'3  rad

-------
18
     Gamma and Bremsstrahlung dose from   Kr inside the body

     1.25 x 10"5 Ct rad/year =

     2.04 x 10-6 ca rad/year =  6.12 x 10'7 rad

     Internal beta dose =

     4.62 x 10~3 Ct rad/year =

     7.58 x 10"4 Ca rad/year =   2.27 x 10~4 rad

                         Total   4.25 x 10~3 rad



                        OTHER DOSE CALCULATIONS
     Depth-dose calculations presented by Hendrickson (203, 204) illus-
trate the discrepancies between the surface dose and the actual dose in
several critical tissues (ignoring contributions from °5Kr in the body).
The results of these calculations, which include contributions from beta,
gamma, and Bremsstrahlung,  for an 85j(r concentration of 3 x 10~7 p-Ci/cm3
are given in table 1.
            TABLE l.a  ANNUAL DOSE FROM IMMERSION IN AIR
            WITH A CONCENTRATION OF 3 x 10 ~7 jaCi(85Kr)/Cm3
Tissue
Whole Body
Gonads
Gonads
Surface of Skin
(or clothing)
Skin
(shallowest layer
Lens of Eye
Lung

Tissue
Depth
(mm)
50
10
2
0.0

0.07
of live skin)
2
(Internal Sur-
face of Lung)
(3
Radiation
(rem/yr)
Nil
Nil
4 x 10"7
0.5

0.3

4 x 10"7
0.005b

x and y
Radiation
(rem/yr)
0.007
0.007
0.007
0.007

0.007

0.007
0.007

     aFrom Hendrickson (203).
     ^Internal exposure to surface lung tissue from 85Kr in the lung.

-------
                                                                    19
     Detailed calculations  of  doses  resulting  from immersion in  infinite
clouds  of the various  reactor-produced noble gases, including  85Kr, using
the MIKD11 methodology are  nearing completion  and will be published in the
near future  (205).

     Relationships  for calculating doses  to various organs resulting from
inhalation or injection of  85Kr  during the medical diagnostic  procedures
previously mentioned have been derived by Lassen (206) who estimates that
the following doses would result from breathing 85j(r at a concentration
of 1 p-Ci/cm3 for 1  minute:

     Tracheal mucosa    71.9  mrad
     Lungs              27.3  mrad
     Adipose tissue      4.2  mrad
     Other (incl. gonads) 0.5  mrad

These values would  change relative to each other as exposure time increases,
The original paper  should be  consulted for details.
      COMPARISON OF  DOSES DELIVERED AT  (MPC)a WITH PERMITTED DOSES

      ICRP  9  (207)  summarizes  dose  limits  for occupational exposure and
exposure to members  of the  public  as  shown  in table  2.  An additional
limit is the  recommended whole  population genetic limit of 5 rems/30 years
(0.167 rem/year).

            TABLE  2a.   SUMMARY  OF DOSE LIMITS FOR INDIVIDUALS

                        Maximum Permissible Doses.
Organ or Tissue          for Adults Exposed in        Dose Limits for
                        the Course of Their Work   Members of the Public
	(rems in a year)	(rems in a year)

Gonads,  red bone                   5                         0.5
  marrow, whole body

Skin, bone,  thyroid               30                         3

Hands and  forearms,                75                         7.5
  feet and  ankles

Other single organs                15                         1.5

      aFrom ICRP-9 (208) .
    11 Medical  Internal  Radiation Dose  Committee  of the  Society of Nuclear
Medicine.

-------
 20
     Figure 7 shows the fractions of applicable limits delivered by  ^5Kr
at a concentration of 3 x 10~? p,Ci/on3, to the skin, gonads, and whole
body.  The full bar in each case represents the fraction given  in  an infi-
nite cloud with exposure time long with respect to body saturation time.
The shaded area of the bar represents the fraction delivered without the
external gamma/Bremsstrahlung component.  The numbers in parentheses are
the factor by which the (MPC)a is conservative for each case.   It  appears
that the (MPC)a is conservative by a factor of at least 4.8 and, when
shielding effects of clothing and buildings are considered, probably by  a
much larger factor.  Modifying factors of particular importance in the
occupational situation are heavy clothing, such as lab coats, and  the
absence of an infinite cloud with respect to gamma radiation.  For example,
if 50 mg/cm^ of clothing is worn reasonably close to the body, the skin
    1
                    •V
                                 I
                                        = INFINITE CLOUD VALUES
                                        = EXTERNAL GAMMA COMPONENT
                                         1
I
!
                                                         "X      "X
  Figure 7.  Comparison of estimations of annual  dose rates  from

-------
                                                                   21
beta dose would  be  18% of  the unclothed dose so the total skin dose/year
at  3 x 10'7 yCi/cm3  would be  0.112 rad beta + 0.005 rad gamma or 0.117
rad/year.12  This  is conservative by a factor of 25.6.  The controlling
dose would then be the extremity dose which is conservative by a factor
of  7.5/0.628 = 12.

     An  increase in  the unrestricted (MPC)a by a factor of 5 and the occu-
pational (MPC)a by a factor of 10-12 would appear justifiable if the only
consideration is meeting existing dose limits, but may not be desirable
when other things  are considered.
              UNEXPLAINED PHENOMENA  INVOLVING  "INERT" GASES

     A number of  inert  gas phenomena, reported in the literature, have
not been satisfactorily explained.   These have all occurred at pressures
many times  greater  than those considered in radiation protection, but
may be applicable to  the physiological behavior of ^Kr and must be con-
sidered.  The relative  mangitude of  effects found with members of the helium
series usually have been in order of polarizability or oil solubility which
is Xe > Kr  > A  > Ne  >  He.


     The growth of  Neurospora arassa was inhibited by 50% with 0.8 atm.
of Xe, 1.6  atm. of  Kr,  3.8 atm. of A, 35 atm. of Ne and 300 atm. of He
(208); the  inhibition of growth at 650 mm pressure was found to be pro-
portional to the  square root of the  atomic weight of the gas.

     High pressures of  xenon (225 psi) led to cessation of motion, a
decrease in contractile vacuole activity, increase in cell volume and
surface area and  cytoloysis in paramecia (209).  Krypton produced a de-
crease in contractile vacuole activity at 915 psi.

     Reversible inhibition of Na+ transport across frog skin was found at
200 psi xenon or  950-1000 psi krypton (210).  Similar pressures caused
reversible  blockage of  frog sciatic  nerve transmission.  In similar frog
nerve-muscle preparations, 100 psi xenon caused a decrease in muscle con-
traction and nerve  conduction and 200 psi krypton decreased muscle con-
traction (211).

     Radioprotection  by inert gases  is reported for animals  (212) and
bean sprouts (8)  although krypton had no protective effect on mice at 2
atmospheres pressure  (213).  Markoe  et at.  (214) reported potentiation  of
killing of  HeLa cells by x rays which was proportional to the partial pre-
sure of Xe  or Kr  present at irradiation.
12Since the limits for members of the public are each 1/10 of the
corresponding occupational limit, the degree of conservativeness calculated
for one applies to the other.

-------
22
     Possibly the most interesting mystery is the demonstrated anesthetic
action of xenon  (6) in humans.  Surgical procedures (orchidectomy and
Fallopian tube ligation) have been performed using an 80% Xe:20% 02 mix-
ture (1 atm. total pressure) for anesthesia.  Higher partial pressures of
Xe are required  to anesthetise animals.  The narcotic potency of the
helium series seems to follow the order previously stated (215) although
narcotic effects of krypton are equivocal at atmospheric pressures  (6).

     Mother observation that has not been accounted for is the uptake of
11/2   2 times  as much inert gas by the adrenal as by any other tissues
(8).

     The foregoing phenomena are not understood at this time although
they have been widely debated (3, 7, 8) .   The most popular postulates,
particularity for anesthesia, are membrane effects involving lipid solu-
bility or stabilization of the formation of hydrate microcrystals in the
nervous system to block electrical conduction.
                     SAMPLING AND ANALYSIS OF 85RR


                         DETECTION AND COUNTING

GENERAL

     Krypton 85 has been successfully detected and counted by virtually
every conventional beta or gamma detection technique, and some unconven-
tional ones, when sampling methods and counting techniques have been
properly matched with the amount and concentration of isotope to be ana-
lyzed and its physical form or configuration.


DETECTORS USED

     GM Counters:  GM counting has been used extensively in the medical
studies cited.  End window GM detectors were used to count the beta radi-
ation emitted from the surface of organs, thin-windowed sample containers,
or flowing gas mixtures.  Internal GM counters have been used to analyze
environmental samples (43).

     The detection efficiency of end-window GM tubes is determined by
many factors and may approach 50% with good geometry and thin windows.
Martin (192) showed that commercial GM tubes with 30 mg/cm2 walls will
detect 5 x 10"7 |iCi/cm3 of 85Kr in an infinite cloud geometry.  Ludwick
et al.  (194), using a very sensitive tube with a 3.5 mg/cm2 window 50 mm
in diameter, were able to detect the passage of a cloud with a concen-
tration of 10"' p,Ci/cm3.  GM tubes coupled to ordinary survey meters
have been successfully used to assay the concentration of 85Kr in

-------
                                                                   23
pressurized steel cylinders  (216).  Most recently, Smith et al.  (217)
report calibration of several types of GM detectors to 85Kr in a known
fraction of an  infinite cloud.  Their results are shown in table 3.

     GM tubes are commonly used as stack monitors by placing them in a
tank large enough to provide an appreciable fraction of an infinite cloud
(for beta) and  drawing part of the stack flow through the tank (30, 217).

     Internal lonization Counters and Proportional Counters:  The standard
technique of counting radioactive gases in internal proportional counters
or ionization chambers has been used by several authors to analyze 85Kr
in environmental samples  (25, 31, 217-219) and is the method used in
standardization.  Gas flow proportional counting was used in conjunction
with gas-phase  chromatography by Dupuis et al.  (220).  Calibration data
reported by Smith et al.   (217) for various sized ionization chambers is
shown in table  4.  These same chambers were equipped with needle valves
and flowmeters  and used to obtain and count integrated atmospheric samples
near the Nuclear Fuel Services plant by Cochran et al. (30).  Cold trap-
ping of xenon and radon was required.

     lonization -chambers may be used in the flow-through mode as well as
a static mode.  This method was used in characterizing the 8%r concen-
tration used in calibrating GM tubes to infinite cloud geometry (217).


     Scintillation Counters:  Gamma Scintillation   Next to GM counting,
gamma scintillation counting using Nal(Tl) crystals is used most to assay
S5Kr.  The 0.514 MeV gamma photon emitted in about 0.43% of the 85Kr dis-
integrations penetrates tissue or sample containers easily and can be
detected with the Nal (Tl) crystal.  This has been the technique used in
most of the papers reporting whole-body or whole-organ saturation or
desaturation data and in laboratory analyses if the activity was high
enough.  The technique avoids the sample self absorption problems encoun-
tered with GM counting and the preparation problems involved with most
of the following techniques.  However, the low detection efficiency of
the Nal combined with the low gamma emission rate of the °%r results
in very low efficiency.

     Beta Scintillation   Both liquid and solid beta scintillation tech-
niques have been used with 85Kr.  Liquid scintillation has become an
increasingly popular method of counting 85Kr and takes advantage of the
high solubility of Kr in toluene based scintillation cocktails (44, 45,
221, 222).   Very low specific activity samples may require concentration
by cryogenic techniques before counting.  According to Shuping et al.
(44, 45), the lowest concentration that can be analyzed without precon-
centration is about 3 pCi/ml.  Counting efficiency is 92-100% and 0.014
pCi of °5Kr can be counted with good precision.  The limiting problem
with air mixtures is the poor solubility of the air in the scintillator.
The undissolved air forms a pocket and part of the Kr goes out of solu-
tion into the air.

-------
24
       TABLE  3.  MINIMUM DETECTABLE  85KR CONCENTRATIONS  FOR CALIBRATED
              EXTERNAL  p DETECTORS [after  Smith et  al.  (217)]
 Count Time
 Background/Sample

 Detector
 Type (Model)
             ~ ^^, „.. ,      Field MDC  (pCi/cm3)
Long Count3-   Short Countb  Long Count0 Short Countd
Laboratory MDC (pCi/on5)
^ong Coun
 0.5/4 hr
               10/10 min     0.5/4 hr    10/10 min
 2 window pancake GM
   (Eon 8008H)

 1 window pancake GM
  .007
                 .012
.020
.012
(Amperex 18546)
(Eon 8 00 IT)
Cylindrical Probe
(LND 719)
(Eon 5108E)
p Scintillator
(Pilot B)
.011
.014
.011
.013
.016
.024
.025
.024
.024
.029
.042
.040
.043
.046
.045
.027
.025
.024
.028
.029
     Notes on counting conditions:

     (1)  All values assume the MDC = 2s/C^r where s = the standard
          deviation of the measurement  (CPM) and Cor = the calibration
          factor for the detector  (CPM/(pCi/cm3)).

     (2)  Total instrument errors are assumed to be negligible  in  each case,

     (3)  The magnitude of the relative background variations  (2syb/B,
          where B = background CPM and svb = standard deviation due to
          background level fluctuations) assumptions for the four  count-
          ing interval combinations used are denoted by the following:
            Superscript^
                 a
                 b
                 c
                 d
    Relative background variations(2svK)
                 4T81
                 9.8%
                27.4%
                11.8%
     (4)  0.3 pCi/cm (MPC)a for individuals in the general population,
          10CFR20 (19).

-------
                                                                   25
           TABLE 4.  MINIMUM DETECTABLE CONCENTMTIONS FOR
                        IN IONIZATION CHAMBERSa>b
                   ~~         MDC s^KrMDCT
Chamber volume             Chamber Unshielded       Chamber/2" Pb Shields
    (liters)   	(pCi/cm5)	(pCi/cm3)
0.5
1.0
2.8
4.3
	 ^i 	 : 	 1. 	
1.3 x 10-1
1.9 x 10'1
3.9 x 10'2
3.9 x 10'2
1.5 x 10-1
1.5 x 10'1
3.1 x 10"2
2.3 x 10"2
     aCary-Tolbert design  (Applied Physics Corp.).
     bA£ter Smith et al. (217).
     An ingenious counting technique, reported by Sax et al.  (2g3) for
environmental samples, employs cryogenic preconcentration by  5 A molecular
sieves at liquid nitrogen temperatures and counting tubes full of plastic
scintillator shavings.  The shavings are outgassed under vacuum and the
concentrated sample is drawn into the tube by vacuum.  The tubes are
reusable after outgassing.

     Smith et al. (217) also tested Pilot B scintillator for uses similar
to those of GM tubes and found that it was less sensitive than the GM
detectors (see table 3).

     A pressurized scintillation chamber is described by Voice (224).

     Semi-conductor Detectors:  Semiconductor detectors of both the lith-
ium-drifted pi-n (108) and the silicon p-n (225) types have been used in
inert catheters for in vivo monitoring of ^S^r concentrations in the heart
and lungs.

     Integrating Dosimeters:  Thermoluminescent dosimeters and film badges
have both been used for monitoring 85Kr (226).  The major drawback with
both is difficulty in characterizing the exposure as to radiation type and
energy to properly assess dose.

-------
26
 CALIBRATION AND STANDARDIZATION

      Krypton  85 gamma or beta calibration standards are available  from
 the National  Bureau  of  Standards or other suppliers.  Secondary  8bKr
 standards  can be prepared by comparison.  Gamma calibration has  been  done
 with 85Sr  sources, an adequate procedure when only the 0.514 MeV photo-
 peak is used.  The Bremsstrahlung spectrum from ^Kr overwhelms  the
 Compton shelf at lower  energies and precludes using 8bSr without a lower
 discriminator.  Also 198Au has been used as a counting standard  (227)  but
 is not recommended.  GM tubes were calibrated to measure 86Kr beta radi-
 ation by immersion in a 204T1 solution  (228).  Data comparing the  response
 to "Kr in air and calibration factors  are given.
                      SAMPLING AND SAMPLE PREPARATION

      The gaseous  nature  and relative chemical inertness of ° Kr preclude
 using the normal  concentration techniques of drawing air through  a  filter
 or an activated charcoal cartridge at ambient temperature.  With  suffi-
 cient specific activity, an appropriate sample container can be filled
 and counted by any  of the mentioned techniques, or a flow-through sampling
 and counting technique can be used with ionization or proportional  counters.
 For samples of very low  specific activity such as those collected in the
 environment at large,  or samples containing other radioactive  inert gases,
 concentration and/or separation by cryogenic techniques are the usual pro-
 cedures.   Molecular sieves (223, 229), activated charcoal (227, 229,  230),
 silica gel,  vermiculite  and alumina (229) have been successfully  used as
 collectors with liquid nitrogen cooling.  Copper wool was used success-
 fully in a LN2 cooled cold trap to collect Xe (231) and was suggested for
 collection of Kr.   Gas chromatography is becoming popular for  analysis of
 8bKr in the presence of  other noble fission gases (220, 232-234).   Direct
 condensation in LN2 or LOX, followed by redistillation has been used suc-
 cessfully (26,  64).

      In theory, any of the separation techniques discussed under  removing
 85Kr from the air can be used.  The ones not mentioned in this section
 have practical drawbacks such as bulk or less than 100% recovery.   All of
 the adsorbing media have a finite capacity.  The quantity of media  used
 and the operating temperature must be matched to the flow rate and  the
 sample size  required,  and the system must be tested in its designed ser-
 vice before  field use  is attempted.

-------
                                                                   27
                                SUMMARY

     Krypton 85 is an environmental contaminant for which progress in
development of monitoring and control methodology appears to have out-
stripped knowledge and understanding of its biologic effects.  Monitoring
methods presently available, while subject to improvement, are adequate
for routine use and several reasonable techniques for removing °%r from
effluent gas streams have been demonstrated on at least pilot plant scale.
On the other hand, the value judgments regarding the necessity for and
stringency of control of release have been and are being based on calcu-
lations and extrapolations rather than on experimental data obtained with
living systems.  Data on the effects of both acute and chronic exposure
of several animal species to ^Kr are needed to confirm these extrapola-
tions .

     Until the behavior and effects of radioactive noble gases in living
systems are better understood, the basis for release regulations will
continue to be founded entirely on radiation dose calculations.   These
calculations should be subjected to the scrutiny of in vivo experimenta-
tion.  In the interim, control of the major source of SS^r release, fuel
reprocessing plants, to the lowest practical emission level is desirable.
It may be appropriate, especially if the (MPC)a for unrestricted areas is
relaxed, to require these plants and any other major source that may
develop to control their release to levels much lower than necessary to
reach the (MPC)a at plant boundaries.

     Relaxation of the occupational (MPC)a, albeit justifiable by cal-
culations, is subject to the same reservations.  It appears more desirable
to grant exceptions or modifications in individual cases for variations
in exposure conditions, such as wearing of heavy clothing or absence of
an infinite cloud, than to change the standard at this time.

-------
                                                                      29
                                REFERENCES


 1.  Chernick, C.L.  The chemistry of the noble gases.  United States
     Atomic Energy Commission, Division of Technical Information, Library
     of Congress Catalog Card Number:  67-62972, (1967).

 2.  Streng, A.G. and A.V. Grosse.  Acid of krypton and its barium salt.
     Science 143:242-243 (1964).

 3.  Featherstone, R.M.  The molecular pharmacology of anesthesia.  Fed.
     Proc. 27:870-871  (1968).

 4.  Lindquist, K.O. and .W.S. Diethorn.  Kinetics of rare gas release from
     hydroquinone clathrates.  Int. J. Appl. Radiat. Isot. 19:333-344
     (1968) .

 5.  Balek, V.  Radioactive inert gases   tool for analysis.  Anal. Chem.
     42:16A-18; 20A; 22A-3; 25A-6; 28A; 30A-1 (August 1970).

 6.  Cullen, S.C. and E.G. Gross.  The anesthetic properties of xenon in
     animals and human beings, with additional observations on krypton.
     Science 113:580-582 (1951).

 7.  Pauling, L.  A molecular theory of general anesthesia.  Science
     134:15-21 (1961).

 8.  Featherstone, R.M. and C.A. Muehlbaecher.  The current role of inert
     gases in the search for anesthesia mechanisms.  Pharmacol.  Rev.
     15:97-121 (1962).

 9.  Nussbaum, E.  Radon solubility in body tissues and in fatty acids.
     Ph.D. Thesis, University of Rochester, Dept. of Radiation Biology
     (1957).

10.  Cryogenic Reference Data.  Union Carbide Corp., Linde Division (1967).

11.  Radiological Health Handbook (Rev.).  Bureau of Radiological Health
     and the Training Institute, Environmental Control Administration,
     U.S. Dept. of Health, Education and Welfare, Public Health Service,
     Consumer Protection and Environmental Health Service, Rockville,
     Md.  20852 (January 1970).

12.  National Bureau of Standards.  Certificate (Provisional), Standard
     Reference Material 4235, Radioactivity Standards Krypton-85.
     Washington, D.C.  20234, (October 1969).

13.  Coleman, J.R. and R. Liberace.  Nuclear power production and estimated
     krypton-85 levels.  Radiol. Health Data Rep. 7:615-621 (1966).

14.  Katcoff, S.  Fission-product yields from neutron-induced fusion.
     Nucleonics 18:203 (November 1960).

-------
30
 15.   Katcoff,  S. and W. Rubinson.  Yields of 85Kr in thermal neutron fis-
      sion of  235U and  239pu.  j. inorg. Nucl. Chem. 27:1447-50  (July 1965).

 16.   Meek, M.E. and B.F. Rider.  Summary of fission product yields for
      U-235, U-238, Pu-239, and Pu-241 at thermal, fission spectrum and
      14 MeV neutron energies.  APED-5398-A, General Electric Co.  (Oct.
      1968).

 17.   Burris,  L.J. and  I.G. Dillon.  Estimation of fission product spectra
      in discharged fuel from fast reactors.  ANL-5742, U.S. AEG, Washington,
      B.C.  20545  (July  1957).

 18.   Weaver,  C.L. and  E.D. Harward.  Surveillance of nuclear power reactors.
      Public Health Rep. 82(10):899-912 October 1967).

 19.   Standards for Protection Against Radiation.  10 CFR 20.

 20.   National  Committee on Radiation Protection, Recommendations "Maximum
      Permissible Body  Burdens and Maximum Permissible Concentrations of,
      Radionuclides in  Air and in Water for Occupational Exposure."
      National  Bureau of Standards, Handbook 69 (1959).

 21.   International Commission on Radiological Protection, Recommendations.
      "Report  of Committee II on Permissible Dose for Internal Radiation
      (1959)."  Pergamon Press, (1960).
 •
 22.   Loevinger, R., E.M. Japha and G.L. Brownell.  "Discrete Radioisotope
      Sources." in Radiation Dosimetry, G.J. Hine and G.L. Brownell, Ed.
      Academic  Press, New York  (1956).  Chapt. 16, pp. 693-799.

 23.   Goussev,  N.G., O.A. Kochetkov, L.M. Mikhailov, A.D. Tourkin, E.G.
      Trukhmanova and V.P. Filipovitch.  Contribution to the setting up
      of standards for  inert radioactive gases.  Health Phys. 12:1836
      (1966).   (Abstract of paper given at 1st IRPA meeting-1966).

 24.   Dunster,  H.J., and B.F. Warner.  The disposal of noble gas fission
      products  from the reprocessing of nuclear fuel.  U.K. Atomic Energy
      Authority, Authority Health and Safety Branch Report.  AHSB(RP)R
      101, Conf. 691039-1 (1970).

 25.   Ehhalt, D., K.O Munnich, W. Roether, J. Scholch and W. Stich.
      Krypton-85 in the atmosphere.  PTOC. 3rd Int. Conf. Peaceful Uses
      Atomic Energy.  Vol. 14 pp. 45-47  (1964).

 26.   Kigoshi,  K.  Krypton-85 in the atmosphere.  Bull. Chem. Soc. Japan
      35:1014-1016 (1962).

 27.   Logsdon,  J.E. and R.I. Chissler.  Radioactive waste discharges to
      the  environment from nuclear power facilities.  BRH/DER 70-2
      Division  of Environmental Radiation, BUS, BRH, Rockville, Md. 20852
      (March 1970).

-------
                                                                  31
28.  Kahn, B. , R.L. Blanchard, H.L. Krieger, H.E. Kolde, D.B. Smith, A.
     Martin,  S. Gold, W.J. Averett, W.L. Brinck, and G.J. Karches.  Radio-
     logical  surveillance studies at a boiling water nuclear power reactor.
     BRH/DER  70-1.  EHS, BRH, Radiological Engineering Laboratory, Divi-
     son of Environmental Radiation, 5555 Ridge Avenue, Cincinnati, Ohio
     45213  (March 1970).

29.  Goode, J.H.  The release of tritium and krypton-85 to the atmosphere
     during processing  of Th02-U0? reactor fuel.  Trans. Am. Nucl. Soc.
     9:21-22  (June 1966).

30.  Cochran, J.A., D.G. Smith, P.J. Magno and B. Shleien.  An investi-
     gation of airborne radioactive effluent from an operating nuclear
     fuel reprocessing  plant.  BRH/NERHL 70-3.  EHS, BRH, Northeastern
     Radiological Health Laboratory, 109 Hoiton Street, Winchester, Mass.
     01890  (July 1970) .

31.  Smith, C.F. and F.F. Momyer.  Studies of chemical and radiochemical
     composition of natural gas from the cavity produced by the Project
     Gasbuggy nuclear shot.  Radiol. Health Data Rep. 10:281-288 (July
     1969) .

32.  Smith, C.F.  Gas quality analysis and evaluation program for Project
     Gasbuggy.  UCRL-72153, Lawrence Radiation Laboratory, University of
     California, Livermore, (December 19, 1969).

33.  Jacobs, D.G. and M.J. Kelly.  Fifth quarterly progress report on the
     theoretical evaluation of consumer products from nuclearly stimulated
     gas wells.  ORNL-TM-2862, Oak Ridge National Laboratory (Feb. 1970),
     AEC   Contract  W-7405-eng-26.

34.  Jacobs, D.G., M.J.  Kelly, K.E. Cowser, S.V. Kaye, P.S. Rohwer, E.G.
     Struxness and W.S.  Snyder.  Dose estimation related to peaceful uses
     of nuclear explosives.  In:ORNL-4446, Health Physics Division Annual
     Progress Report for Period Ending July 31, 1969.  Oak Ridge National
     Laboratory (Oct. 1969), pp. 26-39, AEC Contract W-7405-eng-26.

35.  Smith,  C.F. Jr.  Project Gasbuggy gas quality analysis and evaluation
     program tabulation of radiochemical and chemical analytical results.
     UCRL-50635, Lawrence Radiation Laboratory, Univ. of California, Liver-
     more, (17 Nov.  1969).

36.  Sax, N.I., R.R. Reeves and J.D. Denny.  Surveillance for krypton-85 in
     the atmosphere.  Radiol.  Health Data Rep. 10:99-101 (March 1969).

37.  Delibrias, G. and C.  Jehanno.   Activite de 1'atmosphere due au krypton
     85 (activity of the atmosphere caused by krypton-85).  Bull. Inform.
     Sci. Tech (Paris)  30:14-15 (1959).

-------
 32
38.  Csongor, E.  Radioactivity of the atmosphere.  Fiz. Szemle 20:36-41
     (1970).  Abstract NSA 24-27244 (July 31, 1970).

39.  Bannetier, R.  Original use of the radioactive tracer gas krypton-85
     to study the meridian atmospheric flow.  J. Geophys. Res. 75:2985-2989
     (May 20, 1970).

40.  Raines, A.E.  Isotopic studies of atmospheric methane, ethane and
     krypton.  TID 25284, Arkansas University, Fayetteville (1968), Con-
     tract AT(40-1)-3192.

41.  Shearer, E.G.  Relationships among atmospheric formaldehyde, methane
     and krypton.  TID-25286, Arkansas University, Fayetteville (1969).

42.  Steinberg, M. and B. Manowitz.  Recovery of fission product noble
     gases.  Ind. Eng. Chem. 51(1):47-50 (January 1959).

43.  Ostroski, K,W. and K. Jelen.  On the contamination of atmospheric
     krypton by "Kr from fission products.  Nukleonika 10:61-62 (1965).

44.  Shuping, R.E., C.R. Phillips and A.A. Moghissi.  Low-level counting
     of environmental krypton-85 by liquid scintillation.  SERHL 69-09,
     BRH Southeastern Radiological Health Laboratory, P.O. Box 61,
     Montgomery, Alabama  36101 (1969).

45.  Shuping, R.E., C.R. Phillips and A.A. Moghissi.  Low-level counting
     of environmental krypton-85 by liquid scintillation.  Anal. Chem.
     41:2082-2083 (Dec. 1969).

46.  Cowser, K.E., J. Tadmor, D.G. Jacobs, F.L. Parker, W.J. Boegley,
     G.H. Llewellyn and D.A. Dyslin.  Engineering, economic and safety
     evaluations.  In:  ORNL 4168.  Health Physics Division annual
     progress report for period ending July 31, 1967, Oak Ridge National
     Laboratory.  (Oct. 1967) pp. 39-48.

47.  Cows-er, K.E., J. Tadmor, D.G. Jacobs and W.J. Bpegley  Jr   Evalua-
     tion of environmental hazards from release of 85Kr and ^H in an
     r^?±ng nuclear £uel reprocessing industry.  Health Phys. 13:943
     (1967).  (Abstract of paper at 13th Health Physics Society meeting).

48.  Lasseart, A.H.  and C. Kellershohn.   Spark chambers in nuclear
     medicine.  Nucleonics 24:56 (March 1966).

49.  Federal Radiation Council.   Report No. 4.   "Estimates and Evaluation

     1962-  '(1963)     UnitSd StateS fr°m Nuclear WeaP°ns Testing through

-------
                                                                   33
50.  Whipple, G.H.  Approaches to the calculation of limitations of
     nuclear detonations for peaceful purposes.  In:  Proceedings for
     the Symposium on Public Health Aspects of Peaceful Uses of Nuclear
     Explosives, April  7-11, 1969.  SWRHL-82, CPEHS, EGA, BRH, South-
     western Radiological Health Laboratory, Las Vegas, Nevada.  (1970).
     pp. 684-696.

51.  Shleien, B.  An estimate of radiation doses received by individuals
     living in the vicinity of a nuclear fuel reprocessing plant in 1968.
     BRH/NERHL 70-1.  EHS, BRH, Northeastern Radiological Health Labor-
     atory, 109 Holton  Street, Winchester, Mass.  01890 (May 1970).

52.  Blomeke, J.O. and  J.J. Perona.  Management of noble-gas fission-
     product wastes from reprocessing spent fuels.   ORNL-rIM-2677,
     Chemical Technology Div., Oak Ridge National Laboratory (21 Nov.1969)
     Contract W-7405-eng-26.

53.  Perona, J.J., J.O. Blomeke and W.C.T. Stoddart.  Management of noble-
     gas fission product wastes from reprocessing spent fuels.   Trans.
     Am. Nucl. Soc. 12:449-50 (Nov. 1969).

54.  Zindler, H.  Some  problems of the discharge of radioactive gases and
     aerosols from nuclear installations into the atmosphere.   SZS-16/69
     Staatliche Zentrale fuer Strahlenschutz, Berlin (East Germany)
     (December 1969) Abstract-NSA 24-25252 (July 15, 1970).

55.  Steinberg, M. and  B. Manowitz.  An absorption process for recovery  of
     fission product noble gases.  BNL 493 (T-115), Brookhaven National
     Laboratory (Feb. 1958).

56.  Mclllroy, R.W., E. Glueckauf, H. J. de Nordwall and F.C.W. Pummery.
     The recovery of radiokrypton from dissolved waste gases by fractional
     extraction into solvents.  Proc. 2nd Int. Conf. Peaceful Uses  of
     Atomic Energy.  Vol. 18, United Nations, Geneva (1958)  pp. 190-199.

57-  Glueckauf, E.   Long-term aspect of fission product disposal.  In: Proc.
     1st Int.  Conf. Peaceful Uses of Atomic Energy, Geneva 1966,  Vol. 9,
     p.  3,  United Nations, New York (1956).

58.  Werner, L.  Dynamic behavior of gaseous fission products in charcoal
     adsorber columns.  DP-Report-290, Project Dragon, Atomic Energy
     Establishment, Winfrith, England (March 1965).

59.  Kovach, J.L.  Krypton-xenon adsorption on NACAR carbons.  NACAR 010004,
     Research and Development Dept., North American Carbon, Inc., Columbus,
     Ohio.   (December 28, 1969).

60.  Underbill, D.W.  An experimental analysis of fission-gas holdup beds,
     Nucl.  Applic.  Technol. 8:255-260 (March 1970).

-------
34
61.   Thorny,  A.  and X.  Duval.  Adsorption of  simple molecules  on graphite.
     II.  Variation of  the adsorption potential  as a  function  of the  number
     of adsorbed layers.   J.  Chim.  Phys.  67:286-90  (Feb.  1970).  Abstract
     NSA 24-36976 (September  30,  1970).

62.   Anonymous.  Inexpensive, effective  radioactive-gas  trapper.  Air and
     Water News (October  19,  1970).

63.   Merriman,  J.R., J.H. Pashley and S.H. Smiley.   Engineering develop-
     ment of an absorption process  for the concentration and  collection
     of krypton and xenon. Summary of progress through  July  1,  1967-
     Rept. K-1725. Oak Ridge Gaseous Diffusion Plant  (Dec. 1967).   Con-
     tract W-7405-eng-26.

64.   Merriman,  J.R. and J.H.  Pashley.  Engineering development  of an
     absorption process for the concentration and collection  of krypton
     and xenon.  Fourth summary progress  report, July  through December
     1968.  Rept.  K-1786, Oak Ridge Gaseous  Diffusion  Plant.   (April 1,
     1970).   Contract  W-7405-eng-26.

65.   Bendixsen, C.L.,  G.F. Offutt,  and B.R.  Wheeler.   Rare-gas  recovery
     facility at the ICPP. Trans.  Am. Nucl. Soc. 12:497-498  (Nov. 1969).

66.   Stern,  S.A.  Separation  of krypton  and  xenon from reactor  atmospheres
     by selective permeation. NYO-4057-1, Department  of Chemical Engi-
     neering and Metallurgy,  Syracuse University (1969).   Contract AT
     (30-1)-4057.

67.   Ferguson,  D.E., K.B. Brown,  R.G.  Wymer, R.E. Blanco,  M.E.  Whatley,
     H.E. Goeller and  R.E. Brookshank.  Annual  Progress  Report  for period
     ending  May 31, 1969.  ORNL-4422.  Chemical Technology Division, Oak
     Ridge National Laboratory, October  1969.   Part  4.   Waste Treatment
     and Disposal.

68.   Clark,  W.E. and R.E. Blanco.   Encapsulation of  noble fission product
     gases in solid media prior to  transportation and  storage.   ORNL-4473.
     Oak Ridge National Laboratory,  (Feb. 1970).  Contract W-7405-eng-26.

69.   Reist,  P.C.  The  disposal of radioactive krypton-85 in porous media.
     NYO 841-7, D. Sc. Thesis  Harvard University  (October 29,  1965).

70.   Reist,  P.C.  Steady-state measurement of krypton-85-air  diffusion
     coefficients in porous media.   Environ. Sci. Technol.  1:566-569
     (1967).

71.   Davidsson, D., I. Maclntyre, A.  Rapaport and J.E.S.  Bradley-  Deter-
     mination of total fat in vivo  using °%r.   Biochem.  J. 62:34  (1956).

72.   Lesser, G.T.  and  G.  Zak. Measurement of total  body fat  in man  by
     the simultaneous  absorption  of two  inert gases.   Ann. N.Y.  Acad.  Sci.
     110:40-54 (1963).

-------
                                                                   35
73.  Hytten, F.E.  Measurement of the total body fat in man with
     Proc. Nutr. Soc.  23:xxi  (1964).

74.  Hytten, F.E., K.  Taylor, and N. Taggart.  Measurement of total body
     fat in man.  Clin. Sci.  31(1):111-119  (1966).

75.  Lesser, G.T., W.  Perl, and J.M. Steele.  Determination of total body
     fat by absorption of an  inert gas; measurements and results in normal
     human subjects.   J. Clin. Invest. 39:1791-1806 (1960).

76.  Kety, S.S.  The theory and applications of the exchange of inert gas
     at the lungs and  tissues.  Pharmacol. Rev. 3:1-41 (1951).

77.  Kety, S.S.  Theory of blood-tissue exchange and its application to
     measurement of blood flow.  Methods Med. Res. 8:223-227  (1960).

78.  Sanders, R.J. and R.C. Sullivan.  A method for continuous blood flow
     measurements using krypton-85.  Surg. Forum 13:132-133 (1962).

79.  Sanders, R.J. and R.C. Sullivan.  Continuous regional blood flow
     determinations with radioactive krypton-85.  J. Surg. Res. 3:185-188
     (1963).

80.  Hutten, H.  The influence of diffusion of inert gases on the deter-
     mination of blood flow by the clearance method.  Scand. J. Clin. Lab.
     Invest. 22:Suppl. 102:II-c (1968).

81.  Zierler, K.L.  Basic aspects of kinetic theory as applied to tracer-
     distribution studies.  In:  Dynamic Clinical Studies with Radioisotopes
     R.M. Kniseley and W.N. Tauxe, Ed., U.S. AEC, Div. of Technical Infor-
     mation.  (June 1964) pp. 55-79.

82.  Zierler, K.L.  Equations for measuring blood flow by external monitor-
     ing of radioisotopes.  Circ. Res. 16:309-321 (1965).

83.  Wagner,  H.N., Jr.  Regional blood-flow measurements with krypton-85
     and xenon-133.  In:  Dynamic Clinical Studies with Radioisotopes.
     R.M. Kniseley and W.N. Tauxe, Ed., U.S. AEC, Div. of Technical Infor-
     mation.   (June 1964) pp. 189-212.

84.  Robertson, J.S.   Theory and use of tracers in determining transfer
     rates in biological systems.  Physiol. Rev. 37:133-153 (April 1957).

85.  Rees, J.R.   Radio-Isotopes and regional blood flow.  Br.  Heart J.
     32:137-41 (March  1970).

86.  Harper, A.M.  Measurement of blood flow through organs and tissues
     with inert gases.  Ann. R. Coll. Surg. Eng. 46:126-127 (March 1970).

-------
36
 87.   Ingvar, D.H.  and N.A. Lassen.  Regional blood flow of the cerebral
      cortex determined by krypton85.  Acta. Physiol. Scand. 54:325-338
      (1962).

 88.   McHenry,  L.C., Jr.  Quantitative cerebral blood flow determination.
      Application of a krypton-85 desaturation technique in man.  Neurology
      14:785-793  (1964).

 89.   Alexander,  S.C., H. Wollman, P.J. Cohen, P.E. Chase, E. Melman, and
      M.  Behar.   Krypton  85 and nitrous oxide uptake of the human brain
      during anesthesia.  Anesthesiology 25:37-42  (1964).

 90.   Lassen, N.A.  Blood flow of the cerebral cortex calculated from
      °5krypton beta-clearance recorded over the exposed surface; evidence
      of inhomogeneity of flow.  Acta. Neurol. Scand 41:Suppl 14:24-28
      (1965).

 91.   Nilsson,  N.J.  Observations on the clearance rate of R radiation
                  or
      from krypton8-3 dissolved in saline and injected in microliter
      amounts into  the grey and white matter of the brain.  Acta. Neurol.
      Scand. 41:Suppl. 14:53-57  (1965).

 92.   Lassen, N.A.  and A. Klee.  Cerebral blood flow determined by satura-
      tion and  desaturation with krypton85:  an evaluation of the validity
      of the inert  gas method of Kety and Schmidt.  Circ. Res. 16:26-32
      (1965) .

 93.   Ingvar, D.H., S. Cronquist, R. Ekberg, J. Riseberg and K. Hoedt-
      Rasmussen.  Normal  values of regional cerebral blood flow in man,
      including flow and  weight estimates of gray and white matter.  Acta.
      Neurol. Scand. 41:Suppl. 14:72-78  (1965).

 94.   Kety, S.S.  Measurement of local circulation within the brain by
      means of  inert, diffusible tracers; examination of the theory,
      assumptions and possible sources of error.  Acta. Neurol. Scand.
      41:Suppl  14:20-23  (1965).

 95.   Haggendal,  E., and  B. Johansson.  Effects of arterial carbon dioxide
      tension and oxygen  saturation on cerebral blood flow autoregulation
      in dogs.  Acta. Physiol. Scan. 66:Suppl. 258:27-53 (1965).

 96.   Haggendal,  E.  Effects of some vasoactive drugs on the vessels of
      cerebral  gray matter in the dog.  Acta. Physiol. Scand. 66: Suppl.
      258:55-79 (1965).

 97.   Kety, S.S., W.L. Landau, W.H. Freygang, Jr. L.P. Rowland, and L.
      Sokoloff.   Estimation of regional circulation in the brain by
      uptake of an  inert  gas.  Fed. Proc. 14:85  (1955).

-------
                                                                   37
 98.  Lewis, B.M., L. Sokoloff, W.B. Wentz, R.L. Wechsler, and S.S. Kety.
      Determination of cerebral blood flow using radioactive krypton.  Fed.
      Proc. 14:92  (1955).

 99.  Lassen, N.A. and 0. Munck.  The cerebral blood flow in man determined
      by the use of radioactive krypton.  Acta. Physiol. Scand. 33:30-49
      (1955) .

100.  Lassen, N.A. and 0. Munck.  Cerebral blood flow in arteriovenous
      anomalies of the brain determined by the use of radioactive krypton-85.
      Acta. Physchiat. Neurol. Scand. 31:71-80 (1956).

101.  Albert, S.N., C.A. Albert and J.F. Fazekas.  A rapid and simple method
      for measuring the rate of cerebral blood flow in humans with krypton85
      J. Lab. Clin. Med. 56:473-482  (1960).

102.  Glass, H.I., A.M. Harper and M.M. Glover.  The measurement of local
      cortical blood flow in the brain by the analysis of the clearance
      curve of krypton-85.  Phys. Med. Biol. 6:65-71 (1961).

103.  Harper, A.M., H.I. Glass and M.M. Glover.  Measurement of blood flow
      in the cerebral cortex of dogs by the clearance of krypton-85.   Scott.
      Med. J. 6:12-17 (1961).

104.  Lassen, N.A. and D.H. Ingvar.  The blood flow of the cerebral cortex
      determined by radioactive krypton.  Experientia 17:42-3 (15 Jan 1961).

105.  Ingvar, D.H. and N.A. Lassen.  Quantitative determination of regional
      cerebral blood flow in man.  Lancet 2:806-807 (1961).

106.  Haggendal, E., N.J. Nilsson, and B. Norback.  On the components of
      Kro5 clearance curves from the brain of the dog.  Acta. Physiol.
      Scand. 66:Suppl 258:5-25.

107.  Hoedt-Rasmussen, K.  Regional cerebral blood flow in man measured
      externally following in tr a-arterial administration of 8%r or 133xe
      dissolved in saline.  Acta. Neurol. Scand. 41:Suppl. 14:65-68 (1965).

108.  Appelgren, K.L., D.H. Lewis and E. Haggendal.  A solid state needle
      detector for the determination of regional blood  flow in the brain
      and the kidney by the Kr-85 clearance method.  Scand. J. Clin.  Lab.
      Invest. 17:511-512 (1965).

109.  Fieschi, C., A.  Agnoli, N. Battistini and L. Bozzao.  Relationships
      between cerebral transit time of nondiffusible indicators and
      cerebral blood flow.  A comparative study with krypton-85 and radio-
      albumin.  Experientia 22:189-190 (1966).

110.  Fieschi, C., A.  Agnoli, N. Battistini and L. Bozzao.  Mean transit
      time of a nondiffusible indicator as an index of regional cerebral
      blood flow.  Trans. Am. Neurol. Assoc. 91:224-226 (1966).

-------
38
 111.   Brock,  M.,  D.H.  Ingvar,  and C.W.  Sem Jacobsen.  Regional blood
       flow in deep structures  of the brain measured  in acute cat  experi-
       ments by means  of a new  beta-sensitive  semiconductor needle detector.
       Exp.  Brain.  Res.  4:126-137 (1967).

 112.   Michenfelder, J.D., J.M. Messick, Jr. and R.A. Theye.  Simultaneous
       cerebral blood  flow measured by direct  and  indirect methods.   J.
       Surg. Res.  8:475-481  (October 1968).

 113.   Wollman, H., S.C. Alexander, P.J. Cohen, G.W.  Stephen and L.S.
       Zeigler. Two-compartment analysis of the blood flow in the human
       brain.   Acta. Neurol.  Scand. 41:Suppl 14:79-82  (1965).

 114.   Sokoloff, L. Cerebral blood flow measured  with radioisotopes.   In:
       Dynamic Clinical  Studies with Radioisotopes.   R.M. Kniseley and
       W.N.  Tauxe,  Ed. U.S. AEC, Div. of Technical Information.   (June 1964)
       pp.  153-169.

 115.   Saito,  H. Radioisotopic  diagnostics.  Rinsho Byori 17:781-89
       (October 1969).   Abstract   NSA 24-27629 (July 31, 1970).

 116.   Lewis,  B.M., L.  Sokoloff, R.L. Wechsler, W.B. Wentz, and S.S.  Kety.
       A method for the  continuous measurement of  cerebral blood flow in
       man by  means of radioactive krypton  (Kr?9).  J. Clin. Invest 39:
       707-716 (1960).

 117.   Haggendal,  E.,  D.H. Ingvar, N.A.  Lassen, J. Nilsson, G. Norlen,
       I. Wickbom  and  N.  Zwetnow.  Pre-  and postoperative measurements
       of regional cerebral blood flow in three cases of intracranial
       arteriovenous aneurysms.  J. Neurosurg. 22:1-6  (1965).

 118.   Lassen, N.A., K.  Hoedt-Rasmussen, S.C.  Sorensen, E. Skinhoj, S.
       Cronquist,  B. Bodforss,  and D.H.  Ingvar.  Regional cerebral blood
       flow in man determined by krypton85.  Neurology 13:719-727  (1963).

 119.   Glass,  H.I.  and A.M. Harper.  The measurement  of the partition
       coefficient of  krypton between the brain cortex and blood by a
       double  isotope  method.   Phys. Med. Biol. 7:335-339 (1962).

 120.   Chidsey, C.A. Ill,  H.W.  Fritts, Jr., A. Hardewig, D.W. Richards,
       and A.  Cournand.   Fate of radioactive krypton  (Kr-85) introduced
       intravenously in  man.  J. Appl. Physiol. 14:63-66 (1959).

 121.   Cornell, W.P.,  E. Braunwald and E.G. Brockenbrough.  Use of krypton85
       for the measurement of cardiac output by the single-inject ion  indi-
       cator dilution  technique.  Circ.  Res. 9:984-988 (1961).

 122.   Rochester,  D.F.,  J. Durand, J.O.  Parker, H.W.  Fritts, Jr. and  R.M.
       Harvey.  Estimation of right ventricular output in man using radio-
       active  krypton  (Kr85).   J. Clin.  Invest. 40:643-648  (1961).

-------
                                                                  39
123.  Markason, C.R., H. Smulyan, J.F. Keighley, R.P. Cuddy and R.H. Eich.
      Estimation o£ pulmonary blood flow with the use of krypton85.  J.
      Lab. Clin. Med. 60:714-722  (1962).

124.  Sanders, R.J  and R.G. Sullivan.  Cardiac output determination with
      radioactive "krypton.  J. Surg. Res. 8:522-527 (November 1968).

125.  Prys-Roberts, C.  The measurement of cardiac output.  Br. J. Anesth.
      41:751-60  (Sept. 1969).

126.  Hansen, A.T., B.F. Haxholdt, E. Husfeldt, N.A. Lassen,. 0. Munck,
      H.R. Sorensen and K. Winkler.  Measurement of coronary blood flow
      and cardiac efficiency in hypothermia by use of radioactive kryp-
      ton-85.  Scand. J. Clin. Lab. Invest. 8:182-188 (1956).

127.  Herd, J.A., M. Hollenberg, G.D. Thorburn, H.H. Kopald and A.C.
      Barger.  Myocardial blood flow determined with krypton-85 in unan-
      esthetized dogs.  Am. J. Physiol. 203:122-124(1962)

128.  Cohen, L.S., W.C. Elliott and R. Goblin.  Measurement of mycardial
      blood flow using krypton-85.  Am. J. Physiol. 206:997-999 (1964).

129.  Johansson, B., E. Linder and T. Seeman.  Collateral blood flow in
      the myocardium of dogs measured with krypton-85.  Acta. Physiol.
      Scand. 62:263-270  (1964).

130.  Ross, R.S., K. Ueda, P.R. Lichtlen and J.R. Rees.   Measurement of
      myocardial blood flow in animals and man by selective injection
      of radioactive inert gas into the coronary arteries.  Circ.  Res.
      15:28-41 (1964).

131.  Linder, E.  Measurements of normal and collateral  coronary blood
      flow by close-arterial and intramyocardial injection of krypton-85
      and xenon-133.  Acta. Physiol. Scand. 68:Suppl 272:5-31 (1966).

132.  Norman, J.C., V.H. Covelli and S. Aronow.  Krypton-85 and xenon-133
      myocardial flow measurements in chronically cannulated internal
      mammary transplants.  Surg. Forum 18:110-111 (1967).

133.  Briscoe, W.A., A. Hardewig, G. Emmanuel, P. Gurtner, D. Rochester
      and A. Cournand.  The distribution of blood perfusion to the lung
      in emphysema.  Fed. Proc. 18:59 (1959).

134.  Gurtner, H.P., W.A. Briscoe and A. Cournand.  Studies of the venti-
      lation-perfusion relationships in the lungs of subjects with chronic
      pulmonary emphysema following a single intravenous injection of
      radioactive krypton (Kr-85).  I.  Presentation and validation of
      a theoretical model.  J.  Clin. Invest. 39:1080-1090 (1960).

135.  Arborelius, M. Jr.   Kr85 in the study of pulmonary circulation
      during bronchospirometry.  Scand.  J. Clin. Lab. Invest. 17:253-256
      (1965).

-------
40
 136.  Arborelius, M. Jr.  Kr^5 in the study of pulmonary circulation and
      ventilation during unilateral hypoxia.  Scand. J. Resp. Dis. Suppl.
      62:105-111  (1966).

 137.  Rochester, D.F., R.A. Brown, Jr., W.A. Wichern, Jr., and H.W. Fritts,
      Jr.  Comparison of alveolar and arterial concentrations of °^Kr and
      133xe infused intravenously in man.  J. Appl. Physiol. 22:423-430
       (March 1967) .

 138.  Cellerino, A.F., A. Gaetini, F. Rosso and C. Banaudi.  Uneveness of
      blood and air distribution to the lungs studied by a combined radio-
      krypton and helium method.  J. Nucl. Biol. Med. 11:32-39 (1967).

 139.  Mellemgaard, K.  The alveolar-arterial oxygen difference in chronic
      obstructive lung disease.  Scand. J. Resp. Dis. 48:23-39 (1967).

 140.  Ranson-Bitker, B., M. Leroy Ladurie and J. Durand.  Measurement of
      blood flow distribution of the right and left lungs by bronchospiro-
      metry and excretion of a radioactive isotope of krypton (Kr&5) „
      Respiration 25:395-404 (1968).

 141.  Brun, C. , C. Crone, H.G. Davidson, J. Fabricus, A.T. Hansen, N.A.
      Lassen and 0. Munck.  Renal blood flow in anuric human subject
      determined by use of radioactive krypton-85.  Proc. Soc. Exp. Biol.
      Med. 89:687-690 (1955).

 142.  Thorburn, G.D., H.H. Kopald, J.A. Herd, M. Hollenberg, C.C.C.
      O'Morchoe and A.C. Barger.  Intrarenal distribution of nutrient
      blood flow determined with krypton-85 in the unanesthetized dog.
      Circ. Res. 13:290-307 (1963).

 143.  Bell, G., and A.M. Harper.  Measurement of local blood flow in the
      renal cortex from the clearance of krypton-85.  J. Surg. Res.
      5:382-386 (1965).

 144.  Cosgrove, M.D.  The effect of arterial hypoxia on the blood-flow
      through the renal cortex.  Br. J. Surg. 52:613-617 (1965).

 145.  Ladefoged, J. and F- Pedersen.  Renal blood flow in isolated
      kidneys measured with an electromagnetic flowmeter and by xenon-133
      and krypton-85 wash-out techniques.  Pfluegers Arch. 299:30-37 (1968),

 146.  MacDonald, A.G.  The effect of halothane on renal cortical blood
      flow in normotensive and hypotensive dogs.  Br. J. Anaesth. 41:644-
      655 (1969).

 147.  Bell, G. and A.M. Harper.  Measurement of regional blood flow
      through the skin from the clearance of Kr85.  Nature (London)
      202:704-705 (May 1964).

-------
                                                                  41
148.  Sejrsen, P.  Diffusion processes invalidating the intra-arterial 85-
      Kr beta particle clearance method for measurement of skin blood
      flow in man.  Circ. Res. 21:281-295 (1967).

149.  Sejrsen, P.  Cutaneous blood flow in man studied by freely diffusible
      radioactive indicators.  Scand. J. Clin. Lab. Invest. 19:Suppl 99:
      52-59  (1967).

150.  Jansson, G., M. Kampp, 0. Lundgren and J. Martinson.  Studies on
      the circulation of the stomach.  Acta. Physiol. Scand. 68:Suppl
      277:91  (1966).

151.  Bell, P.R.F- and T. Shelley.  Gastric mucosal blood flow and acid
      secretion in conscious animals measured by heat clearance.  Am. J.
      Dig. Dis. 13:685:696  (1968).

152.  Bell, P.R.F., and C. Battersby.  Effect of vasopressin (Pitressin)
      on gastic mucosal blood flow measured by clearance of krypton".
      Surgery 66:510-514 (September 1969).

153.  Lundgren, 0. and M. Kampp.  The washout of intraarterially injected
      krypton85 from the intestine of the cat.  Experientia 22:268-270
      (1966) .

154.  Kampp, M., 0. Lundgren and J. Sjostrand.  On the components of the
      Kr^S washout curves from the small intestine of the cat.   Acta.
      Physiol. Scand. 72:282-297  (1968).

155.  Kampp, M., and 0. Lundgren.  Blood flow and flow distribution in
      the small intestine of the cat as analyzed by the Kr°5 wash-out
      technique.  Acta. Physiol. Scand. 72:282-297 (1968).

156.  Hollenberg, M. and J. Dougherty.  Liver blood flow measured by
      portal venous and hepatic arterial routes with Kr°5.  Am. J. Physiol.
      210:926-932 (1966).

157.  Birtch, A.G., B.H. Casey, and R.M. Zakheim.  Hepatic blood flow
      measured by the krypton-85 clearance technique.  Surgery 62:174-180
      (July 1967).

158.  Friedman, E., H.H. Kopald, and T.R. Smith.  Retinal and choroidal
      blood flow determined with krypton-85 in anesthetized animals.
      Invest. Ophthalmol. 3:539-546 (1964).

159.  Friedman, E. and T.R. Smith.  Estimation of retinal blood flow in
      animals.  Invest. Ophthalmol. 4:1122-1128 (1965).

160.  Holzman, G.B., H.N. Wagner, M. lio, D. Rabinowitz and K.I. Zierler.
      Measurement of muscle blood flow in the human forearm with radio-
      active krypton and xenon.  Circulation 30:27-34 (1964).

-------
42
 161.   Setchell,  B.P.,  G.M.H. Waites  and  G.D. Thorburn.  Blood  flow  in
       the testis of the  conscious ram measured with krypton   .  effects
       of heat, catecholamines  and acetylcholine.  Circ. Res. 18:755-765
       (1966).

 162.   Gump,  F.E. and R.L. White.  Determination of regional tumor blood
       flow by krypton-85.   Cancer 21:871-875  (May 1968).

 163.   Rosen, R.G.,  C.E.  Silver, J.C. Dougherty and M.L. Som.   The pattern
       of rejection  of  dog laryngeal  grafts.  Surg. Forum  20:479-482 (1969).

 164.   Sanders, R.J.  Use of a  radioactive gas  (Kr^) in diagnosis of
       cardiac shunts.  Proc. Soc. Exp. Biol. Med. 97:1-4  (1958).

 165.   Sanders, R.J.  and  A.G. Morrow.  The localization of circulatory
       shunts with inhaled krypton.  A preliminary clinical report.   Bull.
       Johns Hopkins Hosp. 103:27-31  (1958).

 166.   Long, R.T.L.  and W.P. Cornell.  Experimental detection of left-to-
       right circulatory  shunts with  injections of krypton .   Soc.  Exp.
       Biol. Med. 101:836-838 (1959).

 167.   Sanders, R.J.  and  A.G. Morrow.  The identification  and quantifica-
       tion of left-to-right circulatory  shunts.  Am. J. Med. 26:508-516
       (1959).

 168.   Long, R.T.L.,  E. Braunwald and A.G. Morrow.  Intracardiac injection
       of radioactive krypton.  Clinical  applications of new methods for
       characterization of circulatory shunts.  Circulation 21:1126-1133
       (1960).

 169.   Braunwald, E., A.  Goldblatt, R.T.L. Long and A.G. Morrow.  The
       krypton8^  inhalation  test for the  detection of left-to-right  shunts.
       Br.  Heart  J.  24:47-54 (1962).

 170.   Selzer, A., R.W. Popper  and F. Mintz.  Evaluation of left-to-right
       cardiac shunts.  J. Cardiovasc. Surg. 5:285-291  (1964)

 171.   Weitzman,  D.,  J. McAlister and A.  Houlder.  Localization of left-to-
       right shunts  by  radioactive krypton.  Br. Heart J.  26:577-583 (1964).

 172.   Singleton, R.T., D.H. Dembo and L. Scherlis.  Krypton-85 in the
       detection  of  intracardiac left-to-right-shunts.  Circulation  32:
       134-137 (1965).

 173.   Bekheit, S.,  J.G.  Murtagh, E. Fletcher and P.P. Binnion.  Comparison
       between oxionetry and  "krypton studies in left-to-right  cardiac
       shunts.  Ir.  J. Med.  Sci. 8:169-176 (1969).

-------
                                                                  43
174.  Long, R.T.L., J.A. Waldhausen, W.P. Cornell and R.J.  Sanders.
      Detection of right-to-left shunts:  A new method utilizing injec-
      tions of krypton^S.  proc. Soc. Exp. Biol. Med. 102:456-458 (1959).

175.  Fritts, H.W. Jr., A. Hardewig, D.F. Rochester, J. Durand and A.
      Cournand.  Estimation of pulmonary arteriovenous shunt-flow using
      intravenous injections of T-1824 dye and Kr8\  J. Clin. Invest.
      39:1841-1850 (1960).

176.  Mellemgaard, K., N.A. Lassen and J. Georg.  Right-to-left shunt
      in normal man determined by the use of tritium and krypton-85.
      J. Appl. Physiol. 17:778-782 (1962).

177.  Zaky, H.A., A.R. El-Heneidy and M. Khalil.  Use of krypton-85  in
      the study of hypoxia in porto-pulmonary bilharziasis
      (Shistosomiasis) . Br. Med. J. 5389:1021-1024 (1964).

178.  Cleempoel, H., P. Mercenier, R. Bernard, M. Lebedelle and J.
      Lequime.  The krypton-85 method in the detection of pulmonary
      arterio-venous shunts.  Cardiologia 51:55-63 (1967).

179.  Sanders, R.J. and L.J. Hellerstein.  The diagnosis of right-to-left
      shunts with krypton-85.  J. Surg. Res. 9:441-448 (July 1969).

180.  Long, R.T.L., C.R. Lombardo and E. Braunwald.  Use of radioactive
      krypton and cardio-green dilution curves in the detection of
      experimental portal-systemic venous shunts.  Ann. Surg.  151:146-
      152 (1960).

181.  Cellerino, A.F. and R. Catolla-Cavalcanti.  The slow radioactive
      krypton method using a breath-by-breath counting system in measure-
      ment of blood and gas distribution in separated lungs.  Panminerva
      Med. 7:427-433  (1965).

182.  Byun, H.H., G.  Albrecht, G.W. Holmes and R.S. Landauer.   Pulmonary
      function test using krypton-85.  J. Nucl. Med. 4:345-358 (1963).

""83.  West, J.B.  The use of radioactive materials in the study of lung
      function.  Medical Monograph No. 1, Radiochemical Centre, Amersham
      England (1967).

184.  Dibdin, G.H.  The internal surface and pore structure of teeth.   J.
      Dent. Res. 48:771-776 (Sept.-Oct. 1969).

185.  Robert, L., B.  Robert, J. Medema and J.P.W. Houtman,   Surface  areas
      of elastin samples determined by krypton-85 adsorption.   Biochim.
      Biophys. Acta 214:235-237 (1970).

186.  Geller, E.I., F.X. Worden, G. Cassidy, and C.Y. Bartholomew.  Per-
      sonnel protection program for industrial use of krypton-85. Am.
      Ind. Hyg. Assoc. J. 22:403-408 (1961).

-------
44
 187-   Ellis, W.R.  and B.W. Seatonberry.  A radioisotope method for
       locating points of entry of carbon monoxide into the cabin of an
       aircraft.   Int. J. Appl. Radiat. Isot. 17:81-84  (1966).

 188.   Tsivoglou,  E.G., J.B. Cohen, S.D. Shearer and P.J. Godsil.  Tracer
       measurement of stream aeration.  J. Water Pollut. Contr. Fed.
       40:285-305.

 189.   Corn, M. and T.L. Montgomery.  Atmospheric particulates : specific
       surface  areas and densities.  Science 159:1350-1351  (1968).

 190.   Fries, B.A.  Flow rate measurements of condensable gases by the
       carrier-gas method.  Int. J. Appl. Radiat. Isot. 19:39-42 (1968).

 191.   Robertson,  J.B.  Diffusion from a gaseous source in a porous medium
       a field  and theoretical investigation.  U.S. Geol. Surv., Prof.
       Pap.  650-D:265-273  (1969).

 192.   Martin,  J.E. The correlation of wind tunnel and field measurements
       of gas diffusion using krypton-85 as a tracer.  Ph.D. Thesis, Univer-
       sity of  Michigan, 1965.
 193.   Martin,  J.E.  Methods  of using  85^r as a tracer to study gas emission
       from nuclear  facilities.  Health Phys. 15:175  (Aug. 1968).  Abstract
       of paper given  at 1968 Health Physics Society meeting.

 194.   Ludwick, J.D.,  J.J.  Lashock, R.E. Connaly and P.W. Nickola.  Automatic
       real time air monitoring of  ^%r utilizing the 4096 memory of a multi-
       parameter analyzer.  Rev. Sci.  Instrum. 39:853-859 (June 1968).

 195.   Nikola,  P.W. , J.V. Ramsdell, Jr., and J.D. Ludwick.  Detailed time-
       histories of  concentrations  resulting from puff and short-period
       releases of an  inert radioactive gas :  a volume of atmospheric dif-
       fusion data.  BNWL-1272.  Battelle -Northwest, Richland, Wash. Pacific
       Northwest Lab .,  (Feb.  1970).  Contract AT- (45-1) -1830.

 196.   Nikola,  P.W. , J.V. Ramsdell  and J.D. Ludwick.  Real time histories
       of diffusing  plumes  and puffs determined from use of an inert gas
       tracer system.   BNWL 1307  (pt.  1), pp. 6-10, Battelle -Northwest,
       Richland, Wash.  Pacific Northwest Lab.  (1970).

 197.   Nikola,  P.W.  Measurements of the transport speed and physical dimen-
       sions of a diffusing puff of a  gaseous tracer  in the atmosphere.
       BNWL-1307 (pt.  1)  pp.  10-14, Battelle -Northwest, Richland, Washington,
       Pacific  Northwest Lab. (1970).

 198.   Eddy, W.J. Jr.   Evaluation of cracks  in turbine-blade leading edge
       by use of 85Kr  gas.  Isotop. Radiat. Technol.  7:277-285  (Spring 1970).

-------
                                                                   45
199.  Jech, C.  An  autoradiographic technique for observing channeled
      penetration of  low energy ions.  Appl. Phys. Lett. 15:248-50
       (Oct. 15, 1969).

200.  Jech, C. and  R. Kelly.  Studies on bombardment -induced disorder.
      II.  Formation  of ion-bombardment-induced disorder in zircon,
      corundum, and diamond.  J. Phys. Chem. Solids 31:41-8 (Jan. 1970).
      Abstract NSA  24-21861  (June 15, 1970).

201.  Lukac, P.  Device for preparing radioactive kryptonates by ion
      bombardment.  Radiochem. Radioanal. Lett. 3:121-127 (12 March 1970)
      Abstract NSA  24-21861  (June 15, 1970).

202.  Toelgyessy, J. , V. Jesenak, and E. Koval.  Possible uses of radio-
      active kryptonates of silver in chemical analysis.  J. Radioanal.
      Chem. 4:13-19 (Jan. 1970) (In German) .  Abstract NSA 24-16417,
      May 15, 1970.
203.  Hendrickson, M.M.  The dose from ^Kr released to the earth's
      atmosphere.  BNWL-SA-3233A.  Battelle Memorial Institute, Pacific
      Northwest Laboratory, Richland, Washington 99352.  (July 1970).

204.  Hendrickson, M.M.  The eventual whole body exposure rate from °5Kr
      released to the atmosphere.  Battelle Memorial Institute, Pacific
      Northwest Laboratory, Richland, Washington  99352.  (July 13, 1970).

205.  Russell, J.L. and F.L. Galpin.  Estimated doses to the whole body
      and to the lungs from radioactive noble gases using the MIRD
      methodology.  EPA, Office of Radiation Programs, Division of Techno-
      logy Assessment, Rockville, Maryland  20852.  (In draft   July 1971).

206.  Lassen, N.A.  Assessment of tissue radiation dose in clinical use
      of radioactive inert gases , with examples of absorbed doses from
      3H2, 85Kr and 133Xe.  Minerva Nucleare 8:211-217 (Jul.-Aug. 1964).

207.  ICRP Publication 9.  Recommendations of the International Commission
      on Radiological Protection (Adopted Sept. 17, 1965).  Pergamon Press
      (1966) .

208.  Bucheit, R.G., H.R. Schreiner and G.F. Doebbler.  Growth responses of
      NeuTospora orassa  to increased partial pressures of the noble gases
      and nitrogen.  J. Bacteriol. 21:622-627 (1966).

209.  Sears, D.F-  and S.M. Gittleson.  Cellular narcosis of Popameciwn
      multimioTonuoleatim by xenon and other chemically inert gases.  J.
      Protozool.  11:538-546 (1964).

210.  Gottlieb, S.F., A. Cymerman and A.V. Metz.  Effect of xenon, krypton
      and nitrous oxide on sodium active transport through frog skin with
      additional observations on sciatic nerve conduction.  Aerosp. Med.
      39:449-453 (May 1968).

-------
46
 211.  Gottlieb, S.F.  and J.M.  Weatherly.   Physiological  effects  of  the
       noble gases on frog sciatic nerve and gastrocneraius muscle.   Am.  J.
       Physiol.  208:407-411,  (1965).

 212.  Schreiner, H.R.   General biological  significance of metabolically
       inert gases.   Int.  Anesthesiol.  Clin.  1:919-926  (1963).

 213.  Evans, J.C.,  T.W. Roberts and  L.R. Orkin.  Modification  of radio-
       sensitivity of mice by inert gases and nitrous oxide.  Radiat.  Res.
       21:243-255 (1964).

 214.  Markoe, A.M., R.  Anigstein and R.J.  Schulz.   Effects of  inert gases
       and nitrous oxide on the radiation sensitivity of  HeLa cells.   Phys.
       Med. Biol. 15:200 (Jan.  1970).

 215.  Schreiner, H.R.   General biological  effects  of the helium-xenon
       series of elements.  Fed. Proc.  27:872-878  (1968).

 216.  Williams, K.D.  A rapid determination of the specific  activity  of
       krypton-85 in pressurized cylinders.   J. Nucl. Med. 5:913-919 (1964).

 217.  Smith, D.G.,  J.A. Cochran and  B.  Shleien.  Calibration and initial
       field testing of  S^Rr detectors  for  environmental  monitoring  around
       a nuclear fuel reprocessing facility.   BRH/NERHL 70-4, EHS, BRH,
       Northeastern Radiological Health Laboratory, 109 Holton  Street,
       Winchester, Mass.  01890 (November 1970).

 218.  Anonymous.  Continuous sampler monitor (CMS).  Cape-1985,  Idaho
       Nuclear Corp.,  Idaho Falls (10 Sept.  1969).   Abstract  NSA  24-25169
       (July 15, 1970).

 219.  Tolbert,  B.M.  lonization chamber assay of radioactive gases.   UCRL
       3499, University  of California,  Radiation Laboratory,  Berkeley
       California, (March 5,  1956).

 220.  Dupuis, M.C., G.  Charrier, C.  Alba and D. Massimino.   Possibilities
       of gas-phase  radiochromatography application to permanent  gas
       analysis.  CEA-R-3879.  Commissariat a 1'Energie Atomique, Bruyeres-
       le-Chatel (France)  Centre d'Etudes.  (Jan 1970)  (French).   Abstract
       NSA 24-38744  (Oct.  15, 1970).

 221.  Horrocks, D.L.  and M.H.  Studier.  Determination of radioactive  noble
       gases with a  liquid scintillator.  Anal. Chem. 36:2077-2079 (1964).

 222.  Curtis, M.L., S.L.  Ness and L.L. Bentz.  Simple technique  for rapid
       analysis  of radioactive gases  by liquid scintillation  counting.
       Anal. Chem. 38:636-637 (1966).

 223.  Sax, N.I., J.D. Denny and R.R. Reeves.  Modified scintillation
       counting  technique for determination of low  level  krypton-85.   Anal.
       Chem. 40:1915-1916 (1968).

-------
                                                                  47
224.  Voice, E.H.  A low-level measurement of 85Kr.  DP-Report-109,
      Project Dragon, Atomic Energy Establishment, Winfrith, England
      (Aug. 1962).

225.  Ueda, H. , Y. Sasaki, M. lio, S. Kaihara and I. Ito.   Catheter  semi-
      conductor radiation detector for continuous measurement of caridac
      output.  J. Nucl. Med. 10:713-721 (Dec. 1969).

226.  Terrill, J.G. Jr., C.L. Weaver, E.D. Harward and D.R. Smith.   Envi-
      ronmental surveillance of nuclear facilities.  Nucl.  Safety 9:143-
      149  (Mar.-Apr, 1968) .

227.  Sheibley, D.W.  A simple method for determination of fission gases
      trapped in irradiated fuel forms.  Anal. Chem. 42:142-3 (Jan.  1970).
228.  R^vis, M.A. and J. Shapiro.  Calibration of a CM detector to measure
      °bKr in air by immersion in a standardized 204T1 solution.   Health
      Phys. 13:907-910  (1967).

229.  Jennison, E.  Fission gas collection and trace gas analysis.  Progr.
      Nucl. Energy, Ser. IX; 10:225-54 (1970).

230.  Flygare, J.K. , G. Wehmann, A.R. Harbertson and C.W.  Sill.  A method
      for the collection and identification of radioactive xenon and
      krypton.  TID 7593, Health and Safety Division, AEC, Idaho Falls,
      (Oct. 1960) p. 18-25.

231.  Mantel, J., K.J. Cook and K.E. Corrigan.  Radioactive krypton and
      xenon trapping by cryogenic technics.  Radiology 90:590-591 (1968).

232.  Lengweiler, H.  Experiments on separation procedure for krypton
      and xenon in connection with pluto Loop radiochemical sampling.
      DP-Report-89.  Project Dragon, Atomic Energy Establishment, Winfrith,
      England (Apr. 1962).  Abstract NSA 24-36166 (Sept. 30, 1970).

233.  Charrier, G.  Separation and determination of krypton and xenon by
      gas phase radiochromatography.  CEA-R-3889, Commissariat a 1'Energie
      Atomique,Bruyeres-le-Chatel (France).  Centre d1 Etudes.  (March 1970)
      Abstract NSA 24-26994, (July 31, 1970).

234.  Aubeau, R. , L. Champeix and (Mme) J. Reiss.  Separation et dosage  du
      krypton et du xenon par chromatographie en phase gazeuse.  Applica-
      tion aux gaz de fussion.  J. Chromatog.  6:209-219 (1961).

-------
                                                                  49
                                APPENDIX A
                     ABSORPTION OF KR INTO THE BODY


I.  SOLUBILITY OF 85KR IN VARIOUS MATERIALS:  PARTITION COEFFICIENTS

      (General references    1,2)

     Gas solubility data in the literature are frequently expressed in
terms of either the Bunsen  solubility coefficient  (a) or the Ostwald
solubility coefficient  (L) .  In component units:

                         =  Vo(a) Po
                        a    V     P

where:  Vo(a) = volume of gas absorbed
            V = volume of absorbing fluid
           Po = 760 mm Hg
            P = partial pressure of the gas being
                absorbed in mm Hg

and         L =  a T/To

where:     To = 273° K
            T = 273° K + temperature at which gas  is
                absorbed in °C

     The Ostwald coefficient, L, is also commonly  called the partition
coefficient and is sometimes designated as X.  As  commonly used, a parti-
tion coefficient will be written as A. medium l:medium 2 (example X blood:
air) and is the ratio of the volume concentration  in medium 1 to the
volume concentration in medium 2 at equilibrium.   If \ blood: air = 0.06,
and the air concentration is 1 u,Ci/cm3, the blood  concentration will be
          x 0.06 = 0.06
     The solubility of Kr has been determined in vitro., usually with
degassed solvents, for a number of solvents  and solutions.  These data
are summarized in Table A-l .

2.  IN VIVO PARTITION COEFFICIENTS
     The tissue:air partition coefficient  (A. )  for  an  organ or  system is
 riven by:

  where:   X  tissue:air =  £ (A-:tissue:blood x £•)  A  blood:air
          A.  = tissue:blood partition coefficient  for component  i
          f.  = the fraction of  the organ  or  system made up of  component

-------
50
   TABLE A-l.   SOLUBILITY COEFFICIENTS FOR  85KR  IN VARIOUS SOLVENTSa
Solvent
Olive oil







Water





Saline soln.



/?- albumin


Hemoglobin
soln. (15.41
Blood

Muscle
homogenate

Brain
homogenate

Temp(oC)
45
37


30
25
22
45
45
37

30
25
22
45
37
30
25
37
30
25
37
;)
37

37
30
25
37
30
25
Bunsen Coefficient
0.3844
0.4031
0.43
0.44
0.4225
0.4376
0.44
0.0441
0.0441
0.0481
0.045 (37
0.0539
0.0581
0.059
0.0411
0.0444
0.0499
0.0542
0.0195
0.0412
0.0624
0.0247

0.0455

0.0439
0.0501
0.0549
0.0454
0.0517
0.0572
(ref)
(13)
(13)
(35)
(36)
(13)
(13)
(35)
(14)
(14)
(14)
,35)
(14)
(14)
(35)
(14)
(14)
(14)
(14)
(12)
(12)
(12)
(12)

(12)

(12)
(12)
(12)
(12)
(12)
(12)
Ostwald Coefficient
0.4477 (13)
0.4581 (13)


0.4688 (13)
0.4746 (13)



0.0499 (38)













0.0517 (12)
0.06 (39)







-------
                                                                        51
Solvent Temp(uC)
Human fat









Dog fat



Rat fat



Toluene base
liquid scint.
cocktail
45

37



30

25

45
37
30
25
45
37
30
25

-15

Bunsen Coefficient (ref)
0.3878
0..3875
0.4071
0.4062
0.420
0.414
0.4258
0.4247
0.4412
0.4404
0.3853
0.4031
0.4225
0.4364
0.3847
0.4037
0.4219
0.4363

0.9

(13)
(13)
(13)
(13)
(36)
(36)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)

(40)

Ostwald Coefficient
0.4516
0.4513
0.4626
0.4617
0.425

0.4725
0.4713
0.4816
0.4807
0.4426
0.4581
0.4721
0.4764
0.4481
0.4588
0.4755
0.4762



(13)
(13)
(13)
(13)
(41)

(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)
(13)



   aAddtional 85Kr solubility data in a wide variety of chemicals may be
found in references (2, 42-46).

-------
 52
     If the tissue components, their relative fractions, and their Ostwald
coefficients are known, the tissue:air coefficient can be calculated.  In
practice this is rarely the case and the coefficient is either determined
for the tissue by a dual isotope method such as that of Glass and Harper
(3), or, in many cases, estimated to be the same as that for blood.  A
partial listing of the experimentally determined tissue:air or tissue:
blood partition coefficients for &$Kr follows:

        Tissue     Part     Tissue:Blood     Tissue:Air      Reference

        Brain     Cortex     0.92 (Hc=50)                       4,5
                  White      1.26 (Hc=50)                       4,5
        Kidney    Cortex     1.0                                  6
                             0.96                                 7
                  Medulla    1.0                                  6
        Fat                  9                                    6
                                                0.54              8
                             5                                    5
        Liver                1.06                                 9
                             1.04                                 5
        Eye       Retina     1.0                                  5
        Skeletal             1.0                                  5
           muscle
        Testis               0.85                              5,10
        Blood                               0.05-0.06        Various

Because the coefficients are so similar, Lassen (8), one of the pioneers
in this work, normally uses a tissue:air coefficient of 0.06 for all tis-
sues except fat for which he uses 0.54 (9 x 0.06).  The only significant
variable, for most purposes, is the fat content of the tissue or body
being studied.  Lassen (8) uses a whole-body tissue:air coefficient of
0.11 for lean people, 0.20 for normal weight people, and 0.30 for obese
people.  The calculated coefficient for standard man is 0.163.

     Whole-body partition coefficients and kinetic parameters for female
Rochester Wistar rats, weighing about 250 grams, were experimentally deter-
mined by saturating the animals with 8%r in a closed exposure system for
12 1/2 or 33 1/2 hours, then whole-body counting in a 3- x 5-inch Nal well
crystal until the count reached background (about 12 hours).  The average
seven determinations on four animals was 0.0921 (S. D. = 0.0188).  The
coefficient for one animal that died during the 12 1/2 hour run, deter-
mined by counting component pieces,  was 0.0958.  The value predicted for
rats of 320 grams, using the tissue composition data of Caster, et a£.(ll),
and the solubility data of Yeh and Peterson (12, 13, 14) was 0.076.  Using
Lassen's coefficients (8) and the Caster fat fraction of 0.0708 of the
body weight, a value of 0.094 would be predicted.

-------
                                                                        53
 3-  KINETICS OF 85KR ABSORPTION AND DESORPTION IN THE BODY

      The rate of absorption of 85Kr into the tissues of the body during
 exposure and desorption after exposure or injection of the isotope is a
 complex function of the tissue :blood partition coefficients and, partic-
 ularly, the blood circulation in the tissue in question.  The curves
 obtained will have as many exponential components as there are differently
 perfused elements in the tissue being studied.  Kety (1) has discussed the
 Kinetics involved in detail.  For a single tissue, with the concentration
 in alveolar air considered constant and blood- tissue diffusion time con-
 sidered negligible (actually less than 1 sec.), the following equations
 apply:

      Saturation:    Ci = A^C^(1   e~kt)

    Desaturation:    C-j  = C- f ^e~kt
                     1    HO)
where:   C^  = concentration in tissue i  at time t,  pCi/cm3
         \i  = tissue: air partition coefficient
         C^  = concentration in air,  yCi/cm^
         k  = F-^/V-L  where F^ = blood flow rate in tissue  i,  and V^  =  volume
               of  tissue i

      The quantity of gas in the  tissue  (Qi)  = ViCi or Qi = V^C^l   e"kt)

in saturation.  Q.^(m-]  = ^i^i^a-   F°r tne whole body,  or  a  multiple  compartment

tissue,   Q  = Q1Ca>)Cl   e-klt)  +  Q^ (1   e^ + .  .  .  Q^ (1   e^t) ^

saturation  and similarly for desaturation:
     Most investigators have found at least 2-4 components in their satu-
ration and desaturation curves with 8%r.  The exceptions have been when a
GM counter was being used to count the beta emissions from a homogenous
surface layer thicker than the maximum beta range such as the cerebral
cortex or renal cortex.  Wherever Nal detectors were used or heterogenous
tissues were counted, monoexponential curves were rarely found (15-32) .

     Experimental observations in dogs, cats, and humans (4, 6, 7 , 10, 15-32)
indicate that there are three or four groups of similarly perfused tissues
that can be treated as compartments for purposes of whole-body analyses.
There is a fast component, with T 1/2 from 0.04-0.8 min, which may be due
to arterial blood content.  Three slower compartments are usually seen with
average half times of about 2.5 minutes, 7.5 minutes, and 20-30 minutes
(range of 1-5, 5-10 and 11-180 minutes).  Anything that changes blood flow
rate can radiaally change the observed compartmental half-times in satura-
tion or desaturation and can even cause an apparent change in the number
of compartments observed.

-------
54
     Lesser and Zak  (33) proposed a three-compartment parallel model con-
sisting of:
             1.  Rapidly perfused lean tissues such as the heart, brain,
                 kidneys, etc.
             2.  More slowly perfused lean tissues such as resting muscle,
                 skin, connective tissue, etc.
             3.  Adipose tissue.

While this is obviously an oversimplification, it will suffice for the
purpose of this discussion.

     The relative contribution of the various compartments to the whole-
body burden at full  saturation  (Q^) is determined by the size of the com-
partment, V-, the tissue:air partition coefficient, A-, and the gas concen-
tration in air provided the factors are known.  Hypothetical saturation
and desaturation curves for standard man are shown in Figure A-l.

     Experimental saturation/desaturation data are usually plotted on
semilog paper and resolved into components graphically.   Computer curve
stripping techniques have been reported (34).

     Desaturation data obtained with female rats  in the  experiments pre-
viously mentioned were resolved by a stripping technique.   The original
curve and three components for a rat saturated in an °5Rr mixture for
12 1/2 hours are shown in Figure A-2.   The component half times were 3.75
minutes, 22.6 minutes, and 94.2 minutes and the corresponding fractions
of total activity were 0.248,  0.647 and 0.105.  A second experiment,
using the same animal and saturation time of 33 1/2 hours, resulted in the
two-compartment curves shown in Figure A-3 with halftimes and fractional
activities of 15.7 minutes:  0.89, and 85 min:  0.11, respectively.   The.
cause of the differences in curves obtained is not known but may be stress
from prolonged exposure to radiation ( ~ 3000  rad) and chamber dryness
resulting in increased respiration and circulation which increased the
rate of gas exchange from the  tissue to air.   Another possibility is
greater loss of stored fat in  the longer experiment.   A greater weight
loss was noted;  but, since no  food or water balance was  kept, the loss
could not be unequivocally attributed to fat loss.

-------
                                                               55
I
           MINUTES AFTER  BEGINNING OF EXPOSURE
            DESATURATION
CURVE
1
2
3
4
5
COMPONENT
WHOLE BODY
ADIPOSE TISSUE
OTHER LEAN TISSUE
HIGHLY PERFUSED
LEAN TISSUE
BLOOD
QcO/Ca'
11400
8100
2499
471
330
Mmirf1)

0.0277
0.092
0.277
2.77
t j(min)

25
7.5
2.5
0.25
                                          CONDITIONS
                                            1. TISSUE DENSITY- 1.0
                                            2. C^AG85Kr/cm3AlR
                                            3. PARTITION COEFF.:
                                               BLOOD:AIR   =0.06
                                                 FAT:BLOOD=9.0
                                T°TSSUES
                                                   :BLOOD;I-°
  Figure A-l.
 10      20      30      406080100120140160180200

 MINUTES AFTER END OF  EXPOSURE

Hypothetical   Kr saturation and desaturation curves
for standard man.

-------
  io,oocH
    1000^
s
     100^
      10-J
            'Ao(total)=17.834
                     RAT*] , RUN *1
O = ORIGINAL DATA
A = LONGEST COMPONENT STRIPPED
D = 2 LONG COMPONENTS STRIPPED
CURVE
1
2
3
A0(CPM)
1,870
11,532
4,432
t|(min)
94.2
22.6
3.75
k(mirf')
.0074.
.37
.185
                     \2
           n   i   I   r~

               8
10    12
                   HOURS POST  EXPOSURE
         0
  Figure A-2.  Experimental  5^r desaturation
               curves  in rat - short  exposure.
14
         10,000-
                  -Ao(tota|) =11,343 CPM
                                                                                               RAT *] ,RUN*2
                                                                            O= ORIGINAL DATA
                                                                            A= LONG COMPONENT STRIPPED
CURVE
1
2
A0(CPM)
1,596
12,747
t^ (min)
85
15.7
MmirT1)
.00815
.044
                                                          HOURS POST  EXPOSURE
                                          Figure A-3.   Experimental ^^Kr desaturation
                                                        curves  in rat - long exposure.

-------
                                                                        57
                           APPENDIX REFERENCES


 1.  Kety, S.S.  The theory and applications of the exchange of inert gas
     at the lungs and tissues.  Pharraacol. Rev. 3:1-41 (1951).

 2.  Steinberg, M. and B. Manowitz.  An absorption process for recovery
     of fission product noble gases.  BNL 493(1-115).  Brookhaven National
     Lobaratory  (Feb. 1958).

 3.  Glass, H.I. and A.M. Harper.  The measurement of the partition coef-
     ficient of krypton between the brain cortex and blood by a double
     isotope method.  Phys. Med. Biol. 7:335-339 (1962).

 4.  Ingvar, D.H. and N.A. Lassen.  Regional blood flow of the cerebral
     cortex determined by krypton85.  Acta Physiol. Scand. 54:325-338
     (1962) .

 5.  Kampp, M. and 0. Ilundgren.  Blood flow and flow distribution in the
     small intestine of the cat as analyzed by the Kr85 wash-out technique.
     Acta Physiol. Scand. 72:282-297  (1968).

 6.  Thorburn, G.D., H.H. Kopald, J.A. Herd, M. Hollenberg, C.C.C. O'Morchoe
     and A.C. Barger.  Intrarenal distribution of nutrient blood flow deter-
     mined with krypton85 in the unanesthetized dog.  Circ. Res. 13:290-307
     (1965).

 7.  Bell, G. and A.M. Harper.  Measurement of local blood flow in the
     renal cortex from the clearance of krypton85.  J. Surg. Res. 5:
     382-386 (1965).

 8.  Lassen, N.A.  Assessment of tissue radiation dose in clinical use of
     radioactive inert gases, with examples of absorbed doses from ^2,
     85Kr andl33Xe.  Minerva Nucleare 8:211-217 (Jul.-Aug. 1964).

 9.  Hollenberg, M. and J. Dougherty.  Liver blood flow measured by portal
     venous and hepatic arterial routes with Kr85.  Am. J. Physiol. 210:
     926-932 (1966) .

10.  Setchell, B.P., G.M.H. Waites and G.D. Thorburn.  Blodd flow in the
     testis of the conscious ram measured with krypton 85:  effects of
    Jheat, catecholamines and acetylcholine.  Circ. Res.  18:755-765 (1966).

11.  Caster, W.O., J. Poncelet, A.B. Simon and W.D. Armstrong.  Tissue
     weights of the rat.  I. Normal values determined by dissection and
     chemical methods II. Changes following 700 r total body X-irradiation
     Proc. Soc. Exp. Biol. Med. 91:122-129 (1956).

12.  Yeh, S.Y. and R.F.  Peterson.  Solubility of krypton and xenon in
     blood, protein solutions and tissue homogenates.  J. Appl. Physiol.
     20:1041-1047 (1965).

-------
58
13.  Yeh, S.Y. and R.F.  Peterson.   Solubility of carbon dioxide, krypton
     and xenon in lipids.   J.  Pharm.  Sci.  52:433-458 (1963).

14.  Yeh, S.Y. and R.F.  Peterson.   Solubility of carbon dioxide, krypton,
     and xenon in aqueous  solution.  J.  Pharm.  Sci.  53:822-824 (1964).

15.  Glass, H.I., A.M. Harper, and M.M.  Glover.   The measurement of local
     cortical blood flow in the brain by the analysis  of the  clearance
     curve of krypton-85.   Phys. Med. Biol.  6:65-71  (1961).

16.  Lassen, N.A.  Blood flow of the  cerebral cortex calculated from
     85krypton-beta-clearance recorded over  the  exposed surface;  evidence
     of inhomogeneity of flow.  Acta  Neurol.  Scand.  41:24-28  (1965).

17.  Haggendal, E. and B.  Johansson.   Effects of arterial carbon dioxide
     tension and oxygen  saturation on cerebral blood flow autoregulation
     in dogs.  Acta Physiol.  Scand. 66:Suppl. 258:27-53 (1965).

18.  Haggendal, E.  Effects of some vasoactive drugs on the vessels of
     cerebral grey matter  in the dog. Acta  Physiol. Scand. 66:Suppl-
     258:55-79 (1965).

19.  Haggendal, E., N.J. Nilsson and  B.  Norback.   On the components of
     j(r§5 clearance curves from the brain  of the dog.   Acta Physiol.
     Scand. 258:5-25 (1965).

20.  Brock, M., D.H. Ingvar and C.W.  Sem Jacobsen.   Regional  blood flow
     in deep structures  of the brain  measured in acute cat experiments
     by means of a new beta-sensitive semiconductor  needle detector.   Exp.
     Brain. Res. 4:126-137 (1967).

21.  Herd, J.A., M. Hollenberg, G.D.  Thorburn, H.H.  Kopald and A.C. Barger.
     Myocardial blood flow determined with krypton 85  in unanesthetized
     dogs.  Am. J. Physiol. 203:122-124  (1962).

22.  Cohen, L.S., W.C. Elliott and R. Goblin. Measurement of myocardial
     blood flow using krypton 85.   Am. J.  Physiol. 206:997-999 (1964).

23.  Ross, R.S., K. Ueda,  P.R. Lichtlen  and  J.R.  Rees.   Measurement of myo-
     cardial blood flow  in animals and man by selective injection of radio-
     active inert gas into the coronary  arteries.  Circ. Res. 15:28-41
     (1964).

24.  Cosgrove, M.D.  The effect of arterial  hypoxia  on the blood-flow
     through the renal cortex.  Br. J. Surg.  52:613-617 (1965).

25.  MacDonald, A.G.  The  effect of halothane on renal cortical blood flow
     in normotensive and hypotensive  dogs.   Br.  J. Anaesth. 41:704-705
     (1964).

-------
                                                                        59
26.  Bell, G. and A.M. Harper.  Measurement of regional blood flow through
     the skin from the clearance of krypton-85.  Nature (Lond) 202:704-705
     (1964).

27.  Jansson, G., M. Kampp, 0. Lundgren and J. Martinson.   Studies on the
     circulation of the stomach.  Acta Physiol. Scand. 68:Suppl 277:91
     (1966) .

28.  Lundgren, 0. and M. Kampp.  The washout of intraarterially injected
     krypton85 from the intestine of the cat.  Experientia 22:268-270
     (1966) .

29.  Birtch, A.G., B.H. Casey and R.M. Zakheim.  Hepatic blood flow
     measured by the krypton-85 clearance technique.  Surgery 62:174-180
     (July 1967) .

30.  Friedman, E., H.H. Kopald and T.R. Smith.  Retinal and chroidal
     blood flow determined with krypton-85 in anesthetized animals.
     Invest. Ophthalmol. 3:539-546 (1964).

31.  Holzman, G.B., H.N. Wagner, M. lio, D. Rabinowitz and K.I. Zierler.
     Measurement of muscle blood flow in the human forearm with radio-
     active krypton and xenon.  Circulation 30:27-34 (1964).

32.  Tobias, C.A., H.B. Jones, J.H. Lawrence and J.G.  Hamilton.  The
     uptake and elimination of krypton and other inert gases  by the human
     body.  J. Clin. Invest. 28:1375-1385 (1949).

33.  Lesser, G.T.  and G. Zak.  Measurement of total body fat  in man by the
     simultaneous absorption of two inert gases.  Ann. N.Y. Acad.  Sci.
     110:40-54 (1963).
34.  Sveinsdottir, E.  Clearance curves of Kr85 or Xe^33 considered as a
     sum of mono -exponential outwash functions. Description of a computer
     program for the simple case of only two compartments.   Acta Neurol.
     Scand. 41:Suppl. 14:69-71 (1965).

35.  Lawrence, J.H., W.F. Loomis, C.A. Tobias, and F.H.  Turpin.   Prelimi-
     nary observations on the narcotic effect of xenon with a review of
     values for solubilities of gases in water and oils.  J. Physiol.
     105:197-204 (1946).

36.  Masson, M.B.R. and K. Taylor.  Solubility of krypton-85 in olive oil
     and human fat.  Phys. Med. Biol. 12:93-98 (1967).

37.  Lawrie, J.A. , H.R. Schreiner and C.W. Cowley.  Controlled atmosphere
     incubator for physiological studies involving the rare gases.   J. Appl,
     Physiol. 19:330-332 (1964).

-------
60
38.  Hardewig, A., D.F. Rochester and W.A. Briscoe.  Measurement of
     solubility coefficients of krypton in water, plasma, and human blood,
     using radioactive Kr85.  J. Appl. Physiol.. 15:723-725 (1960).

39.  Morrison, T.J. and N.B. Johnson.  Solubilities of the inert gases in
     water.  J. Chem. Soc. 1954:3441-3446 (1954).

40.  Horrocks, D.L. and M.H. Studier.  Determination of radioactive noble
     gases with a liquid scintillator.  Anal. Chem. 36:2077-2079 (1964).

41.  Hytten, F.E., K. Taylor and N. Taggart.  Measurement of total body
     fat in man by absorption of 85Kr.  Clin. Sci. 31:111-119 (1966).

42.  Clever, H.L.  The solubility of argon and krypton in p-xylene and p-
     xylene-p-dihalobenzene mixtures at 30°.  J.  Phys. Chem.  61:1082-1083
     (1957).

43.  Clever, H.L., J.H. Saylor and P.M. Gross.  The solubility of helium,
     neon, argon, krypton and xenon in methylcyclohexane and perfluoro-
     methylcyclohexane.  J. Phys. Chem. 62:89-91 (1958).

44.  Clever, H.L., R. Battino, J.H. Saylor and P.M. Gross.  The solubility
     of helium, neon, argon and krypton in some hydrocarbon solvents.
     J. Phys. Chem. 61:1078-1082) (1957).

45.  Reed, E.L. and J.J. Droher.  Solubility and diffusivity of inert gases
     in liquid sodium, potassium, and NaK.  1MEC-69-36, Atomics Interna*-
     tional, Canoga Park, Calif. Liquid Metal Engineering Center, (31 Jan.
     1970), (Contract AT(04-3) 700).

46.  Yamamoto, Y. and H. Takeda.  Solubility of °%r in some organic sol-
     vents.  Tokyo Daigaku Kogakubu Kiyo, A; 7:44-5 (Dec. 1969).  (In
     Japanese).  Abstract NSA 24-27214.  (July 31, 1970).
                                             U. S. GOVERNMENT PRINTING OFFICE : 1 972--Wt-l(82A6

-------